A review of central 5-HT receptors and their function
Tóm tắt
Từ khóa
Tài liệu tham khảo
Abi-Dargham, 1993, Pharmacological and regional characterisation of [3H]LY278 584 binding sites in human brain, J. Neurochem., 60, 730, 10.1111/j.1471-4159.1993.tb03208.x
Abramowski, 1995, Localization of the 5-hydroxytryptamine2C receptor protein in human and rat brain using specific antisera, Neuropharmacology, 34, 1635, 10.1016/0028-3908(95)00138-7
Adham, 1993, Cell-specific coupling of the cloned human 5-HT1F receptor to multiple signal transduction pathways, Naunyn-Schmiedeberg’s Arch. Pharmacol., 348, 566, 10.1007/BF00167231
Adham, 1993, Cloning of another human serotonin receptor (5-HT1F): a 5th 5-HT1 receptor subtype coupled to the inhibition of adenylate cyclase, Proc. Natl. Acad. Sci. USA, 90, 408, 10.1073/pnas.90.2.408
Adham, 1992, The rat 5-hydroxytryptamine1B receptor is the species homologue of the human 5-hydroxytryptamine1Dβ receptor, Mol. Pharmacol., 41, 1
Adham, 1994, A single point mutation increases the affinity of serotonin 5-HT1Dα, 5-HT1Dβ, 5-HT1E and 5-HT1F receptors for beta-adrenergic antagonists, Neuropharmacology, 33, 387, 10.1016/0028-3908(94)90068-X
Adham, 1994, The cloned human 5-HT1E receptor couples to inhibition and activation of adenylyl cyclase via two distinct pathways in transfected BS-C-1 cells, Neuropharmacology, 33, 403, 10.1016/0028-3908(94)90070-1
Aghajanian, 1972, Influence of drugs on the firing of serotonin-containing neurons in the brain, Fed. Proc., 31, 91
Aghajanian, 1995, Electrophysiology of serotonin receptor subtypes and signal transduction pathways, 1451
Aghajanian, 1997, Serotonin induces excitatory postsynaptic potentials in apical dendrites of neocortical pyramidal cells, Neuropharmacology, 4/5, 589, 10.1016/S0028-3908(97)00051-8
Albert, 1996, The 5-HT1A receptor: signaling, desensitization, and gene transcription, Neuropsychopharmacology, 14, 19, 10.1016/S0893-133X(96)80055-8
Albert, 1990, Cloning, functional expression and messenger RNA tissue distribution of the rat 5-hydroxytryptamine1A receptor gene, J. Biol. Chem., 265, 5825, 10.1016/S0021-9258(19)39437-2
Altman, 1987, Non-cholinergic pharmacology in human cognitive disorders, 346
Amlaiky, 1992, Isolation of a mouse 5HT1E-like serotonin receptor expressed predominantly in hippocampus, J. Biol. Chem., 267, 19761, 10.1016/S0021-9258(19)88617-9
Andrade, 1991, 5-Hydroxytryptamine4-like receptors mediate the slow excitatory response to serotonin in the rat hippocampus, J. Pharmacol. Exp. Ther., 257, 930
Andrade, 1987, Pharmacologically distinct actions of serotonin on single pyramidal neurones of the rat hippocampus recorded in vitro, J. Physiol. Lond., 394, 99, 10.1113/jphysiol.1987.sp016862
Andrews, 1993, Increased 5-HT release mediates the anxiogenic response during benzodiazepine withdrawal—a review of supporting neurochemical and behavioural evidence, Psychopharmacology, 112, 21, 10.1007/BF02247359
Andrews, 1994, 5-HT1A receptors in the median raphe and dorsal hippocampus may mediate anxiolyic and anxiogenic behaviours respectively, Eur. J. Pharmacol., 264, 259, 10.1016/0014-2999(94)00473-0
Andrews, 1997, Evidence that the median raphe nucleus-dorsal hippocampal pathway mediates diazepam withdrawal-induced anxiety, Psychopharmacology, 130, 228, 10.1007/s002130050233
Ansanay, 1992, Characterisation of homologous 5-hydroxytryptamine4 receptor desensitisation in colliculi neurons, Mol. Pharmacol., 42, 808
Ansanay, 1996, Pharmacological comparison between [3H]GR113 808 binding sites and functional 5-HT4 receptors in neurons, Eur. J. Pharmacol., 298, 165, 10.1016/0014-2999(95)00786-5
Araneda, 1991, 5-hydroxytryptamine2 and 5-hydroxytryptamine1A receptors mediate opposing responses on membrane excitability in rat association cortex, Neuroscience, 40, 399, 10.1016/0306-4522(91)90128-B
Arborelius, 1994, The 5-HT1A receptor antagonist (S)-UH-301 blocks the (R)-8-OH-DPAT-induced inhibition of serotonergic dorsal raphe cell firing in the rat, J. Neural Transm., 96, 179, 10.1007/BF01294785
Arnt, 1984, The citalopram/5-HTP-induced head shake syndrome is correlated to 5-HT2 receptor affinity and also influenced by other transmitters, Acta Pharmacol. Toxicol., 55, 363, 10.1111/j.1600-0773.1984.tb01996.x
Artigas, 1996, Acceleration of the effect of selected antidepressant drugs in major depression by 5-HT1A antagonists, Trends Neurosci., 19, 378, 10.1016/S0166-2236(96)10037-0
Ashby, 1994, Electrophysiological evidence for a functional interaction between 5-HT1A and 5-HT2A receptors in the rat medial prefrontal cortex: an iontophoretic study, Synapse, 17, 173, 10.1002/syn.890170306
Ashby, 1994, Effect produced by acute and chronic administration of the selective 5-HT3 receptor antagonist BRL46470 on the number of spontaneously active midbrain dopamine cells in the rat, Drug Dev. Res., 31, 228, 10.1002/ddr.430310310
Assie, 1996, (−)-Pindolol and (±)-tertatolol affect rat hippocampal 5-HT levels through mechanisms involving not only 5-HT1A, but also 5-HT1B receptors, Neurophramacology, 35, 213, 10.1016/0028-3908(95)00169-7
Azmitia, 1996, Cellular localization of the 5-HT1A receptor in primate brain neurons and glial cells, Neuropsychopharmacology, 14, 35, 10.1016/S0893-133X(96)80057-1
Bachy, 1993, SR-57227A—a potent and selective agonist at central and peripheral 5-HT3 receptors in vitro and in vivo, Eur. J. Pharmacol., 237, 299, 10.1016/0014-2999(93)90282-M
Baez, 1990, Pharmacological and molecular evidence that the contractile response to serotonin in rat stomach fundus is not mediated by activation of the 5-hydroxytryptamine(1C) receptor, Mol. Pharmacol., 38, 31
Baker, 1998, Stimulation of type 1 and type 8 Ca2+/calmodulin-sensitive adenylyl cyclases by the Gs-coupled 5-hydroxytryptamine subtype 5-HT7A receptor, J. Biol. Chem., 273, 17469, 10.1074/jbc.273.28.17469
Bard, 1993, Cloning of a novel human serotonin receptor (5-HT7) positively linked to adenylate cyclase, J. Biol. Chem., 268, 23422, 10.1016/S0021-9258(19)49479-9
Barker, 1994, Constitutively active 5-hydroxytryptamine2C receptors reveal novel inverse agonist activity of receptor ligands, J. Biol. Chem., 269, 11687, 10.1016/S0021-9258(17)32625-X
Barnes, 1990, Characterisation and autoradiographic localisation of 5-HT3 receptor recognition sites identified with [3H]-(S)-zacopride in the forebrain of the rat, Neuropharmacology, 29, 1037, 10.1016/0028-3908(90)90110-D
Barnes, 1989, Identification and characterisation of 5-HT3 recognition sites in human brain tissue, J. Neurochem., 53, 1787, 10.1111/j.1471-4159.1989.tb09244.x
Barnes, 1989, 5-HT3 receptors mediate inhibition of acetylcholine release in cortical tissue, Nature, 338, 762, 10.1038/338762a0
Barnes, 1990, The effects of ondansetron, a 5-HT3 receptor antagonist, on cognition in rodents and primates, Pharmacol. Biochem. Behav., 35, 955, 10.1016/0091-3057(90)90385-U
Barnes, 1992, Molecular characteristics of excitatory amino acid receptors, Programme Neurobiol., 39, 113, 10.1016/0301-0082(92)90007-2
Barnes, 1992, Differential modulation of extracellular levels of 5-hydroxytryptamine in the rat frontal cortex by (R)- and (S)-zacopride, Br. J. Pharmacol., 107, 233, 10.1111/j.1476-5381.1992.tb14492.x
Barone, 1993, Quantitative autoradiography of 5-HT1E binding sites in rodent brains: effect of lesion of serotonergic neurones, Eur. J. Pharmacol., 249, 221, 10.1016/0014-2999(93)90436-L
Bartus, 1982, The cholinergic hypothesis of geriatric memory dysfunction, Science, 217, 408, 10.1126/science.7046051
Baxter, 1996, Novel discriminatory ligands for 5-HT2B receptors, Behav. Brain Res., 73, 149, 10.1016/0166-4328(96)00087-3
Baxter, 1994, Further characterization of 5-hydroxytryptamine receptors (putative 5-HT2B) in rat stomach fundus longitudinal muscle, Br. J. Pharmacol., 112, 323, 10.1111/j.1476-5381.1994.tb13072.x
Baxter, 1995, 5-HT2 receptor subtypes: a family re-united?, Trends Pharmacol. Sci., 16, 105, 10.1016/S0165-6147(00)88991-9
Beck, S.G., Bacon, W.L., 1998a. 5-HT7 receptor mediated inhibition of sAHP in CA3 hippocampal pyramidal cells. Fourth IUPHAR Satellite meeting on Serotonin, Rotterdam, S1.3.
Beck, 1998, 5-HT7 receptor mediated inhibition of sAHP in CA3 hippocampal pyramidal cells, Soc. Neurosci. Abstr., 24, 435.4
Beer, 1992, An investigation of the 5-HT1D receptor binding affinity of 5-hydroxytryptamine, 5-carboxyamidotryptamine and sumatriptan in the central nervous system of seven species, Eur. J. Pharmacol., 213, 193, 10.1016/0014-2999(92)90681-S
Belelli, 1995, Cloning and functional expression of a human 5-hydroxytryptamine type 3As receptor subunit, Mol. Pharmacol., 48, 1054
Benloucif, 1993, Serotonin-facilitated dopamine release in vivo-pharmacological characterisation, J. Pharmacol. Exp. Ther., 265, 373
Bentley, 1995, Therapeutic potential of 5-HT3 receptor antagonists in neuropsychiatric disorders, CNS Drugs, 3, 363, 10.2165/00023210-199503050-00005
Berendsen, 1990, Involvement of 5-HT1C-receptors in drug-induced penile erections in rats, Psychopharmacology, 101, 57, 10.1007/BF02253718
Berman, 1997, Effect of pindolol in hastening response to fluoxetine in the treatment of major depression: a double-blind, placebo-controlled trial, Am. J. Psychiatry, 154, 37, 10.1176/ajp.154.1.37
Bervoets, 1993, 5-HT1A receptors and the tail-flick response. IV. Spinally localized 5-HT1A receptors postsynaptic to serotoninergic neurones mediate spontaneous tail-flicks in the rat, J. Pharmacol. Exp. Ther., 264, 95
Bianchi, 1990, 5-HT1A agonists increase and 5-HT3 agonists decrease acetylcholine efflux from the cerebral cortex of freely-moving guinea-pigs, Br. J. Pharmacol., 101, 448, 10.1111/j.1476-5381.1990.tb12728.x
Bill, 1991, Direct evidence for an important species difference in the mechanism of 8-OH-DPAT-induced hypothermia, Br. J. Pharmacol., 103, 1857, 10.1111/j.1476-5381.1991.tb12342.x
Bird, 1990, Huntington’s disease, 221
Björk, 1991, Pharmacology of the novel 5-hydroxytryptamine1A receptor antagonist (S)-5-fluoro-8-hydroxy-2-(dipropylamino)tetralin: inhibition of (R)-8-hydroxy-2-(dipropylamino)tetralin-induced effects, J. Pharmacol. Exp. Ther., 258, 58
Blandina, 1988, Activation of a 5-HT3 receptor releases dopamine from rat striatal slices, Eur. J. Pharmacol., 155, 349, 10.1016/0014-2999(88)90528-6
Blandina, 1989, Realease of endogenous dopamine by stimulation of 5-hydroxytryptamine-3 receptors in rat striatum, J. Pharm. Exp. Ther., 251, 803
Blier, 1993, 5-HT3 receptors which modulate [3H]5-HT release in the guinea-pig hypothalamus are not autoreceptors, Synapse, 15, 143, 10.1002/syn.890150206
Blier, 1990, Differential responsiveness of the rat dorsal and median raphe 5-HT systems to 5-HT1 receptor agonists and p-chloroamphetamine, Synapse, 5, 120, 10.1002/syn.890050206
Bliss, 1993, A synaptic model of memory-long-term potentiation in the hippocampus, Nature, 361, 31, 10.1038/361031a0
Blondel, 1997, Molecular and functional characterization of a 5-HT4 receptor cloned from human atrium, FEBS Lett., 412, 465, 10.1016/S0014-5793(97)00820-X
Blondel, 1998, Cloning, expression, and pharmacology of four human 5-hydroxytryptamine4 receptor isoforms produced by alternative splicing in the carboxyl terminus, J. Neurochem., 70, 2252, 10.1046/j.1471-4159.1998.70062252.x
Blondel, 1998, The 5-HT4 receptor antagonist ML10375 inhibits the constitutive activity of human 5-HT4(C) receptor, Br. J. Pharmacol., 125, 595, 10.1038/sj.bjp.0702163
Blue, 1988, Correspondence between 5-HT2 receptors and serotonergic axons in rat neocortex, Brain Res., 453, 315, 10.1016/0006-8993(88)90172-2
Bobker, 1994, A slow excitatory postsynaptic potential mediated by 5-HT2 receptors in nucleus prepositus hypoglossi, J. Neurosci., 14, 2428, 10.1523/JNEUROSCI.14-04-02428.1994
Bobker, 1989, Serotonin agonists inhibit synaptic potentials in the rat locus ceruleus in vitro via 5-hydroxytryptamine1A and 5-hydroxytryptamine1B receptors, J. Pharmacol. Exp. Ther., 250, 37
Bockaert, 1990, Pharmacological characterisation of 5-hydroxytryptamine4 (5-HT4) receptors positively coupled to adenylate cyclase in adult guinea pig hippocampal membranes: effect of substituted benzamide derivatives, Mol. Pharmacol., 37, 408
Bockaert, 1998, Molecular biology, function and pharmacological role of 5-HT4 receptors, Naunyn-Schmiedeberg’s Arch. Pharmacol., 358, 1.4
Boddeke, 1990, Zacopride and BRL24924 induce an increase in EEG-energy in rats, Br. J. Pharmacol., 101, 281, 10.1111/j.1476-5381.1990.tb12701.x
Boddeke, 1992, Agonist effects at putative central 5-HT4 receptors in rat hippocampus by R(+)- and S(−)-zacopride: no evidence for stereoselectivity, Neurosci. Lett., 134, 261, 10.1016/0304-3940(92)90530-K
Boeijinga, 1993, Serotonergic modulation of neurotransmission in the rat subicular cortex in vitro: a role for 5-HT1B receptors, Naunyn-Schmiedeberg’s Arch. Pharmacol., 348, 553, 10.1007/BF00167229
Boeijinga, 1996, Activation of 5-HT1B receptors suppresses low but not high frequency synaptic transmission in the rat subicular cortex in vitro, Brain Res., 721, 59, 10.1016/0006-8993(96)00149-7
Boess, 1995, Ultrastructure of the 5-hydroxytryptamine(3), J. Neurochem., 64, 1401, 10.1046/j.1471-4159.1995.64031401.x
Boess, 1994, Molecular biology of 5-HT receptors, Neuropharmacology, 33, 275, 10.1016/0028-3908(94)90059-0
Boess, 1997, Functional and radioligand binding characterisation of rat 5-HT6 receptors stably expressed in HEK293 cells, Neuropharmacology, 36, 713, 10.1016/S0028-3908(97)00019-1
Boess, 1998, The 5-hydroxytryptamine6 receptor-selective radioligand [3H]Ro 63-0563 labels 5-hydroxytryptamine receptor binding sites in rat and porcine striatum, Mol. Pharmacol., 54, 577, 10.1124/mol.54.3.577
Bonhaus, 1995, The pharmacology and distribution of human 5-hydroxytryptamine2B (5-HT2B) receptor gene products: comparison with 5-HT2A and 5-HT2C receptors, Br. J. Pharmacol., 115, 622, 10.1111/j.1476-5381.1995.tb14977.x
Bonhaus, 1997, RS-102221: a novel high affinity and selective, 5-HT2C receptor antagonist, Neuropharmacology, 36, 621, 10.1016/S0028-3908(97)00049-X
Bonhomme, 1995, Evidence for 5-HT4 receptor subtype involvement in the enhancement of striatal dopamine release induced by serotonin: a microdialysis study in the halothane-anesthetized rat, Neuropharmacology, 34, 269, 10.1016/0028-3908(94)00145-I
Boschert, 1994, The mouse 5-hydroxytryptamine1B receptor is localized predominantly on axon terminals, Neuroscience, 58, 167, 10.1016/0306-4522(94)90164-3
Bouhelal, 1988, 5-HT1B receptors are negatively coupled with adenylate cyclase in rat substantia nigra, Eur. J. Pharmacol., 151, 189, 10.1016/0014-2999(88)90799-6
Bourson, 1995, Determination of the role of the 5-HT6 receptor in the rat brain: a study using antisense oligonucleotides, J. Pharmacol. Exp. Ther., 274, 173
Bourson, 1996, Pharmacologic evaluation of the discriminative stimulus of metachlorophenylpiperazine, Pharmacol. Biochem. Behav., 53, 107, 10.1016/0091-3057(95)00207-3
Bourson, 1998, Involvement of 5-HT6 receptors in nigro-striatal function in rodents, Br. J. Pharmacol., 125, 1562, 10.1038/sj.bjp.0702230
Bradley, 1986, Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine, Neuropharmacology, 25, 563, 10.1016/0028-3908(86)90207-8
Bradwejn, 1994, The cholecystokinin hypothesis of anxiety and panic disorder, Ann. N.Y. Acad. Sci., 713, 273, 10.1111/j.1749-6632.1994.tb44075.x
Brennan, 1997, A gene knockout model of serotonin 5-HT6 receptor function, Soc. Neurosci. Abstr., 23, 116.9
Briddon, 1998, Comparative desensitization of the human 5-HT2A and 5-HT2C receptors expressed in the human neuroblastoma cell line 5H-SY-5Y, Br. J. Pharmacol., 125, 727, 10.1038/sj.bjp.0702145
Bruinvels, 1993, Autoradiographic characterisation and localisation of 5-HT1D compared to 5-HT1B binding sites in rat brain, Naunyn-Schmiedeberg’s Arch. Pharmacol., 347, 569, 10.1007/BF00166939
Bruinvels, 1994, Localization of 5-HT1B, 5-HT1Dα, 5-HT1E and 5-HT1F, receptor messenger RNA in rodent and primate brain, Neuropharmacology, 33, 367, 10.1016/0028-3908(94)90067-1
Bruinvels, 1994, A comparative autoradiographic study of 5-HT1D binding sites in human and guinea-pig brain using different radioligands, Brain Res. Mol. Brain Res., 21, 19, 10.1016/0169-328X(94)90374-3
Bruinvels, 1994, 5-hydroxytryptamine1 recognition sites in rat brain: heterogeneity of non-5-hydroxytryptamine1A/1C binding sites revealed by quantitative receptor autoradiography, Neuroscience, 53, 465, 10.1016/0306-4522(93)90210-7
Buchheit, 1986, The rat isolated stomach fundus strip, a model for 5-HT1C receptors, Br. J. Pharmacol., 88, 367P
Bufton, 1993, Distribution and characterisation of the [3H]granisetron-labelled 5-HT3 receptor in the human forebrain, Neuropharmacology, 32, 1325, 10.1016/0028-3908(93)90027-Z
Bühlen, 1996, Evidence for presynaptic location of inhibitory 5-HT1D beta-like autoreceptors in the guinea-pig brain cortex, Naunyn-Schmiedeberg’s Arch. Pharmacol., 353, 281, 10.1007/BF00168629
Burns, 1997, Regulation of serotonin-2C receptor G-protein coupling by RNA editing, Nature, 387, 303, 10.1038/387303a0
Burt, 1991, GABAA receptor subtypes: from pharmacology to molecular biology, FASEB J., 5, 2916, 10.1096/fasebj.5.14.1661244
Busatto, 1997, Perspectives on the role of serotonergic mechanisms in the pharmacology of schizophrenia, J. Psychopharmacol., 11, 3, 10.1177/026988119701100102
Burnet, 1995, The distribution of 5HT1A and 5-HT2A receptor mRNA in human brain, Brain Res., 676, 157, 10.1016/0006-8993(95)00104-X
Cadogan, 1994, Social interaction increases 5-HT release and cAMP efflux in the rat ventral hippocampus in vivo, Behav. Pharmacol., 5, 299, 10.1097/00008877-199406000-00007
Canton, 1990, Binding of typical and atypical antipsychotics to 5-HT1C and 5-HT2 sites: clozapine potently interacts with 5-HT1C sites, Eur. J. Pharmacol., 191, 93, 10.1016/0014-2999(90)94100-C
Canton, 1996, Identification, molecular cloning, and distribution of a short variant of the 5-hydroxytryptamine2C receptor produced by alternative splicing, Mol. Pharmacol., 50, 799
Cardenas, 1997, 5HT4 receptors couple positively to tetrodotoxin-insensitive sodium channels in a subpopulation of capsaicin-sensitive rat sensory neurons, J. Neurosci., 17, 7181, 10.1523/JNEUROSCI.17-19-07181.1997
Carey, 1992, Ondansetrron and arecoline prevent scopolamine-induced cognitive deficits in the marmoset, Pharmacol. Biochem. Behav., 42, 143, 10.1016/0091-3057(92)90458-R
Carli, 1995, (S)-WAY 100 135, a 5-HT1A receptor antagonist, prevents the impairment of spatial learning caused by intrahippocampal scopolamine, Eur. J. Pharmacol., 283, 133, 10.1016/0014-2999(95)00310-H
Carli, 1997, WAY 100 635, a 5-HT1A antagonist, prevents the impairment of spatial learning caused by intrahippocampal administration of scopolamine or 7-chloro-kyneurenic acid, Eur. J. Pharmacol., 774, 167
Carson, 1996, The 5-HT5A serotonin receptor is expressed predominantly by astrocytes in which it inhibits cAMP accumulation: a mechanism for neuronal suppression of reactive astrocytes, Glia, 17, 317, 10.1002/(SICI)1098-1136(199608)17:4<317::AID-GLIA6>3.0.CO;2-W
Casanovas, 1996, Differential effects of ipsapirone on 5-hydroxytryptamine release in the dorsal and median raphe neuronal pathways, J. Neurochem., 67, 1945, 10.1046/j.1471-4159.1996.67051945.x
Cassel, 1995, Downregulation of muscarinic and 5-HT1B-mediated modulation of [3H]acetylcholine release in hippocampal slices of rats with fimbria-fornix lesions and intrahippocampal grafts of septal origin, Brain Res., 704, 153, 10.1016/0006-8993(95)01092-0
Castro, 1997, Differential distribution of [3H]sumatriptan binding sites (5-HT1B, 5-HT1D and 5-HT1F) in human brain: focus on brain stem and spinal cord, Neuropharmacology, 36, 535, 10.1016/S0028-3908(97)00061-0
Castro, 1997, Identification and characterisation of a new serotonergic recognition site with high affinity for 5-carboxamidotryptamine in mammalian brain, J. Neurochem., 69, 2123, 10.1046/j.1471-4159.1997.69052123.x
Ceci, 1994, The inhibitory effect of 8-OH-DPAT on the firing activity of dorsal raphe serotoninergic neurons in rats is attenuated by lesion of the frontal cortex, Neuropharmacology, 33, 709, 10.1016/0028-3908(94)90177-5
Chalmers, 1991, Comparative anatomical distribution of 5-HT1A receptor mRNA and 5-HT1A binding in rat brain-a combined in situ hybridisation/in vitro receptor autoradiographic study, Brain Res., 561, 51, 10.1016/0006-8993(91)90748-K
Chaput, 1990, Pharmacological and functional analysis of a novel serotonin receptor in the rat hippocampus, Eur. J. Pharmacol., 182, 441, 10.1016/0014-2999(90)90041-4
Charney, 1990, Serotonin-specific drugs for anxiety and depressive disorders, Ann. Rev. Med., 41, 437, 10.1146/annurev.me.41.020190.002253
Cheetham, 1993, Evidence that RU 24969-induced locomotor activity in C57/B1/6 mice is specifically mediated by the 5-HT1B receptor, Br. J. Pharmacol., 110, 1621, 10.1111/j.1476-5381.1993.tb14010.x
Chen, 1995, Monoamine interactions measured by microdialysis in the ventral tegmental area of rats treated systemically with (±)-8-hydroxy-2-(di-n-propylamino)tetralin, J. Neurochem., 64, 1585, 10.1046/j.1471-4159.1995.64041585.x
Chen, 1992, The human 5-HT2 receptor is encoded by a multiple intron-exon gene, Mol. Brain Res., 14, 20, 10.1016/0169-328X(92)90005-V
Cheng, 1994, Actions of 5-hydroxytryptophan to inhibit and disinhibit mouse behaviour in the light/dark test, Eur. J. Pharmacol., 255, 39, 10.1016/0014-2999(94)90080-9
Choi, 1997, 5-HT2B receptor-mediated serotonin morphogenetic functions in mouse cranial neural crest and myocardiac cells, Development, 124, 1745, 10.1242/dev.124.9.1745
Cichol, 1998, Assignment of the human serotonin 4 receptor gene (HTR4) to the long arm of chromosome 5 (5q31–q33), Mol. Memr. Biol., 15, 75, 10.3109/09687689809027521
Clarke, 1996, Lack of 5-hydroxytryptamine1A-mediated inhibition of adenylyl cyclase in dorsal raphe of male and female rats, J. Pharmacol. Exp. Ther., 277, 1259
Claeysen, 1997, Assignment of 5-hydroxytryptamine receptor (HTR4) to human chromosome 5 bands q31–q33 by in situ hybridisation, Cytogenet. Cell Genet., 78, 133, 10.1159/000134646
Claeysen, 1997, Cloning and expression of human 5-HT4S receptors. Effect of receptor density on their coupling to adenylyl cyclase, NeuroReport, 8, 3189, 10.1097/00001756-199710200-00002
Claeysen, S., Paye, P., Sebben, M., Taviaux, S., Bockaert, J., Dumuis, A., 1997c. 5-HT4 receptors: from gene to function. In: Proceedings of the Advances in serotonin receptor research. San Francisco, USA, 8–10th October.
Claeysen, 1996, Cloning, expression and pharmacology of the mouse 5-HT4L receptor, FEBS Lett., 398, 19, 10.1016/S0014-5793(96)01132-5
Clemett, 1998, Antisense oligonucleotide-induced reduction in 5-hydroxytryptamine7 receptors in the rat hypothalamus without alteration in exploratory behaviour or neuroendocrine function, J. Neurochem., 71, 1271, 10.1046/j.1471-4159.1998.71031271.x
Clemett, D.A., Kendall, D.A., Marsden, C.A., et al., 1997. Differential effects of chronic clozapine and haloperidol on 5-HT2C and 5-HT7 receptor levels in the rat brain. Br. J. Pharmacol. (in press).
Clifford, 1998, Electrophysiological and neurochemical evidence that pindolol has agonist properties at the 5-HT1A autoreceptor in vivo, Br. J. Pharmacol., 124, 206, 10.1038/sj.bjp.0701796
Cockcroft, 1990, Ligand-gated ion channels: homology and diversity, Mol. Neurobiol., 4, 129, 10.1007/BF02780338
Collingridge, 1990, Excitatory amino acid receptors and synaptic plasticity, Trends Pharmacol. Sci., 11, 290, 10.1016/0165-6147(90)90011-V
Conn, 1986, Regulation of serotonin-stimulated phosphoinositide hydrolysis: relation to the serotonin 5-HT2 binding site, J. Neurosci., 6, 3669, 10.1523/JNEUROSCI.06-12-03669.1986
Conn, 1987, Relative efficacies of piperazines at the phosphoinositide hydrolysis-linked serotonergic (5-HT2 and 5-HT1C) receptors, J. Pharmacol. Exp. Ther., 242, 552
Conn, 1984, Selective 5-HT2 antagonists inhibit serotonin stimulated phosphatidyl inositol metabolism in cerebral cortex, Neuropharmacology, 23, 993, 10.1016/0028-3908(84)90017-0
Conner, 1990, Serotonin receptor-mediated activation of adenylate cyclase in the neuroblastoma NCB20: a novel 5-hydroxytryptamine receptor, Mol. Pharmacol., 37, 742
Consolo, 1994, 5-HT4 receptor stimulation facilitates acetylcholine release in rat frontal cortex, NeuroReport, 5, 1230, 10.1097/00001756-199406020-00018
Consolo, 1994, Serotonergic facilitation of acetylcholine release in vivo from rat dorsal hippocampus via serotonin 5-HT3 receptors, J. Neurochem., 62, 2254, 10.1046/j.1471-4159.1994.62062254.x
Consolo, 1996, Endogenous serotonin facilitates in vivo acetylcholine release in rat frontal cortex through 5-HT1B receptors, J. Pharmacol. Exp. Ther., 277, 823
Cook, 1994, Primary structure of the human platelet serotonin 5-HT2A receptor: identity with frontal cortex serotonin 5-HT2A receptor, J. Neurochem., 63, 465, 10.1046/j.1471-4159.1994.63020465.x
Corradetti, 1992, Serotonin blocks the long-term potentiation induced by primed burst stimulation in the CA1 region of rat hippocampal slices, Neuroscience, 46, 511, 10.1016/0306-4522(92)90140-W
Corradetti, 1996, Electrophysiological effects of N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl) cyclohexane carboxamide (WAY 100 635) on dorsal raphe serotonergic neurons and CA1 hippocampal pyramidal cells in vitro, J. Pharmacol. Exp. Ther., 278, 679
Costall, 1996, 5-HT4 receptor antagonists attenuate the disinhibitory effects of diazepam in the mouse light/dark test, Br. J. Pharmacol., 119, 352P
Costall, 1992, The psychopharmacology of 5-HT3 receptors, Pharmacol. Toxicol., 71, 401, 10.1111/j.1600-0773.1992.tb00570.x
Costall, 1997, The influence of 5-HT2 and 5-HT4 receptor antagonists to modify drug induced disinhibitory effects in the mouse light/dark test, Br. J. Pharmacol., 122, 1105, 10.1038/sj.bjp.0701513
Costall, 1987, Effects of the 5-HT3 receptor antagonist GR38032F, on raised dopaminergic activity in the mesolimbic system of the rat and marmoset brain, Br. J. Pharmacol., 92, 881, 10.1111/j.1476-5381.1987.tb11394.x
Costall, 1989, Neuroanatomical sites of action of 5-HT3 receptor agonists and antagonists for alteration of aversive behaviour in the mouse, Br. J. Pharmacol., 96, 325, 10.1111/j.1476-5381.1989.tb11821.x
Cowen, 1990, Endocrinological responses to 5-HT, Ann. N.Y. Acad. Sci., 600, 250, 10.1111/j.1749-6632.1990.tb16887.x
Cowen, 1996, Moderate dieting causes 5-HT2C receptor supersensitivity, Psychol. Med., 26, 1155, 10.1017/S003329170003587X
Craig, 1990, Pharmacological characterisation of a neuronal receptor for 5-hydroxytryptamine in guinea-pig ileum with properties similar to the 5-hydroxytryptamine4 receptor, J. Pharmacol. Exp. Ther., 252, 1378
Craven, 1994, WAY-100 635 and GR127 935: effects on 5-hydroxytryptamine-containing neurones, Eur. J. Pharmacol., 271, 1, 10.1016/0014-2999(94)90289-5
Craven, 1997, 5-HT2-like receptor-mediated depolarization of 5-HT-containing dorsal raphe neurons in vitro, Br. J. Pharmacol., 120, 261P
Crespi, 1997, 5-HT3 serotonin hetero-receptors inhibit [3H]acetylcholine release in rat cortical synaptosomes, Pharmacol. Res., 35, 351, 10.1006/phrs.1997.0143
Critchley, 1994, Inhibition of 8-OH-DPAT-induced elevation of plasma corticotrophin by the 5-HT1A receptor antagonist WAY 100 635, Eur. J. Pharmacol., 264, 95, 10.1016/0014-2999(94)90642-4
Cutrera, 1996, Phase-shifting effect of 8-OHDPAT, a 5-HT1A/5-HT7 receptor agonist, on locomotor activity in golden hamster in constant darkness, Neurosci. Lett., 210, 1, 10.1016/0304-3940(96)12655-0
Dahlström, A., Fuxe, K., 1964. Evidence for the existence of monoamine-containing neurons in the central nervous system. I. Demonstration of monoamines in the cell bodies of brain stem neurons. Acta Physiol. Scand. 62, Suppl. 232.
Davidson, 1997, WAY 100 135, a partial agonist at native and recombinant 5-HT1B/1D receptors, Br. J. Pharmacol., 121, 737, 10.1038/sj.bjp.0701197
Davidson, 1995, Evidence that 5-hydroxytryptamine release in rat dorsal raphe nucleus is controlled by 5-HT1A, 5-HT1B and 5-HT1D autoreceptors, Br. J. Pharmacol., 114, 1107, 10.1111/j.1476-5381.1995.tb13321.x
Davies, 1999, The 5-HT3B subunit is a major determinant fo serotonin-receptor function, Nature, 397, 359, 10.1038/16941
DeDeurwaerdere, 1997, Serotonin stimulation of 5-HT4 receptors indirectly enhances in vivo dopamine release in the rat striatum, J. Neurochem., 68, 195, 10.1046/j.1471-4159.1997.68010195.x
DeDeurwaerdere, 1998, Opposite change of in vivo dopamine release in the rat nucleus accumbens and striatum that follows electrical stimulation of dorsal raphe nucleus: role of 5-HT3 receptors, J. Neurosci., 18, 6528, 10.1523/JNEUROSCI.18-16-06528.1998
Deecher, 1993, Detection of 5-hydroxytryptamine2 receptors by radioligand binding, northern blot analysis, and Ca2+ responses in rat primary astrocyte cultures, J. Neurosci. Res., 35, 246, 10.1002/jnr.490350304
DeLean, 1982, Dopamine receptor of the porcine anterior-pituitary gland—evidence for two affinity states discriminated by both agonists and antagonists, Mol. Pharmacol., 22, 290
Demchyshyn, 1992, A human serotonin 1D receptor variant (5HT1D beta) encoded by an intronless gene on chromosome 6, Proc. Natl. Acad. Sci. USA, 89, 5522, 10.1073/pnas.89.12.5522
De Montigny, 1984, Electrophysiologically-identified serotonin receptors in the rat CNS: effect of antidepressant treatment, Neuropharmacology, 23, 1511, 10.1016/0028-3908(84)90095-9
De Vivo, 1986, Characterisation of 5-hydroxytryptamine1A-receptor-mediated inhibition of forskolin-stimulated adenylate cyclase activity in guinea-pig and rat hippocampal membranes, J. Pharmacol. Exp. Ther., 238, 248
De Vry, 1995, 5-HT1A receptor agonists: recent developments and controversial issues, Psychopharmacology, 121, 1, 10.1007/BF02245588
Dı́ez-Ariza, 1998, Differential interaction between 5-HT3 receptors and GABAergic neurons inhibiting acetylcholine release in rat entorhinal cortex slices, Brain Res., 801, 228, 10.1016/S0006-8993(98)00562-9
Dijk, 1995, NMDA-induced glutamate and aspartate release from rat cortical pyramidal neurones: evidence for modulation by a 5-HT1A antagonist, Br. J. Pharmacol., 115, 1169, 10.1111/j.1476-5381.1995.tb15020.x
Di Matteo, 1998, Selective blockade of serotonin2C/2B receptros enhances dopamine release in the rat nucleus accumbens, Neuropharmacology, 37, 265, 10.1016/S0028-3908(98)00014-8
Doménech, 1994, Identification and characterisation of serotonin 5-HT4 receptor binding sites in human brain: comparison with other mammalian species, Mol. Brain Res., 21, 176, 10.1016/0169-328X(94)90392-1
Done, 1994, Biochemical evidence for the regulation of central noradrenergic activity by 5-HT1A and 5-HT2 receptors: microdialysis studies in the awake and anaesthetized rat, Neuropharmacology, 33, 411, 10.1016/0028-3908(94)90071-X
Done, 1992, Evidence that 5-HT2 receptor activation decreases noradrenaline release in rat hippocampus in vivo, Br. J. Pharmacol., 107, 240, 10.1111/j.1476-5381.1992.tb14493.x
Doucet, 1995, In situ hybridization evidence for the synthesis of 5-HT1B receptor in serotoninergic neurons of anterior raphe nuclei in the rat brain, Synapse, 19, 18, 10.1002/syn.890190104
Doménech, 1997, Characterization of human serotonin 1D and 1B receptors using [3H]-GR-125743, a novel radiolabelled serotonin 5HT1D/1B receptor antagonist, Naunyn-Schmiedeberg’s Arch. Pharmacol., 356, 328, 10.1007/PL00005058
Downie, 1995, The interaction of trichloroethanol with murine recombinant 5-HT3 receptors, Br. J. Pharmacol., 114, 1641, 10.1111/j.1476-5381.1995.tb14952.x
Dulawa, 1997, Characterisation of exploratory behavior and sensorimotor gating in wild type and serotonin 5A knockout mice, Soc. Neurosci. Abstr., 23, 482.20
Duman, 1997, A molecular and cellular theory of depression, Arch. Gen. Psychiatry, 54, 597, 10.1001/archpsyc.1997.01830190015002
Dumuis, 1988, A nonclassical 5-hydroxytryptamine receptor positively coupled with adenylate cyclase in the central nervous system, Mol. Pharmacol., 34, 880
Duxon, 1997, Evidence for the expression of the 5-hydroxytryptamine2B receptor protein in the rat central nervous system, Neuroscience, 76, 323, 10.1016/S0306-4522(96)00480-0
Duxon, 1997, Activation of 5-HT2B receptors in the medial amygdala causes anxiolysis in the social interaction test in the rat, Neuropharmacology, 36, 601, 10.1016/S0028-3908(97)00042-7
Edgar, 1993, Serotonin and the mammalian circadian system. II. Phase-shifting rat behaviour rhythms with serotonergic agonists, J. Biol. Rhythms, 8, 17, 10.1177/074873049300800102
Eglen, 1997, The 5-HT7 receptor: orphan found, Trends Pharmacol. Sci., 18, 104, 10.1016/S0165-6147(97)01043-2
Eiselé, 1993, Chimaeric nicotinic-serotonergic receptor combines distinct ligand binding and channel specificities, Nature, 366, 479, 10.1038/366479a0
Eison, 1992, The behavioural effects of a novel substance P analogue following infusion into the ventral tegmental area and like substantia nigra of the rat brain, Brain Res., 238, 137, 10.1016/0006-8993(82)90777-6
Elswood, 1991, Identification of putative 5-HT4 receptors in guinea-pig ascending colon, Eur. J. Pharmacol., 196, 149, 10.1016/0014-2999(91)90421-L
Engel, 1986, Identity of inhibitory presynaptic 5-hydroxytryptamine (5-HT) autoreceptors in the rat brain cortex with 5-HT1B binding sites, Naunyn-Schmiedeberg’s Arch. Pharmacol., 332, 1, 10.1007/BF00633189
Erdmann, 1996, The human serotonin 7 (5-HT7) receptor gene: genomic organisation and systematic mutation screening in schizophrenia and bipolar affective disorder, Mol. Psychiatry, 1, 392
Erlander, 1993, Two members of a distinct subfamily of 5-hydroxytryptamine receptors differentially expressed in rat brain, Proc. Natl. Acad. Sci., 90, 3452, 10.1073/pnas.90.8.3452
Fagni, 1992, The 5-HT4 receptor subtype inhibits K+ current in colliculi neurones via activation of a cyclic AMP-dependent protein kinase, Br. J. Pharmacol., 105, 973, 10.1111/j.1476-5381.1992.tb09087.x
Fargin, 1988, The genomic clone G-21 which resembles a β-adrenergic receptor sequence encodes the 5-HT1A receptor, Nature, 335, 358, 10.1038/335358a0
Fayolle, 1988, 5-Hydroxytryptamine stimulates two distinct adenylate cyclase activities in rat brain: high-affinity activation is related to a 5-HT1 subtype different from 5-HT1A, 5-HT1B, and 5-HT1C, Fundam. Clin. Pharmacol., 2, 195, 10.1111/j.1472-8206.1988.tb00632.x
Feng, 1987, Progressive sequence alignment as a prerequisite to correct phylogenetic trees, J. Mol. Evol., 25, 351, 10.1007/BF02603120
Feuerstein, 1996, 5-HT1D-like receptors inhibit the release of endogenously formed [3H]GABA in human, but not in rabbit, neocortex, Neurosci. Lett., 209, 210, 10.1016/0304-3940(96)12637-9
Fillion, 1975, Serotonin sensitive adenylate cyclase in horse brain synaptosomal membranes, Life Sci., 24, 1813, 10.1016/0024-3205(79)90072-9
Fink, 1995, Subclassification of presynaptic 5-HT autoreceptors in the human cerebral cortex as 5-HT1Dβ receptors, Naunyn-Schmiedeberg’s Arch. Pharmacol., 352, 451, 10.1007/BF00172785
Fiorella, 1995, 5-HT2C receptor-mediated phosphoinositide turnover and the stimulus effects of m-chlorophenylpiperazine, Psychopharmacology, 122, 237, 10.1007/BF02246545
Fletcher, 1993, WAY 100135: a novel, selective antagonist at presynaptic and postsynaptic 5-HT1A receptors, Eur. J. Pharmacol., 237, 283, 10.1016/0014-2999(93)90280-U
Fletcher, 1993, Silent 5-HT1A receptor antagonists: utility as research tools and therapeutic agents, Trends Pharmacol. Sci., 14, 41, 10.1016/0165-6147(93)90185-M
Fletcher, 1996, Electrophysiological, biochemical, neurohormonal and behavioural studies with WAY 100635, a potent, selective and silent 5-HT1A receptor antagonist, Behav. Brain Res., 73, 337, 10.1016/0166-4328(96)00118-0
Fletcher, 1997, Purification of 5-hydroxytryptamine3 receptors from porcine brain, Br. J. Pharmacol., 122, 655, 10.1038/sj.bjp.0701439
Fletcher, 1998, Desperately seeking subunits: are native 5-HT3 receptors really homomeric complexes?, Trends Pharmacol. Sci., 19, 212, 10.1016/S0165-6147(98)01210-3
Fletcher, 1998, Evidence that porcine native 5-HT3 receptors do not contain nicotinic acetylcholine receptor subunits, Neuropharmacology, 37, 397, 10.1016/S0028-3908(98)00052-5
Foguet, 1992, Cloning and functional characterization of the rat stomach fundus serotonin receptor, EMBO J., 11, 3481, 10.1002/j.1460-2075.1992.tb05427.x
Foguet, 1992, Structure of the mouse 5-HTD1C, 5-HT2 and stomach fundus serotonin receptor genes, NeuroReport, 3, 345, 10.1097/00001756-199204000-00014
Fontana, 1997, The effects of novel, selective 5-hydroxytryptamine (5-HT)4 receptor ligands in rat spatial navigation, Neuropharmacology, 4/5, 689, 10.1016/S0028-3908(97)00055-5
Forbes, 1998, (R)-3,N-Dimethyl-N-[1-methyl-3-(4-methyl-piperidin-1-yl)propyl] benzenesulfonamide): the first selective 5-HT7 receptor antagonist, J. Med. Chem., 41, 655, 10.1021/jm970519e
Fornal, 1994, Effects of the putative 5-hydroxytryptamine1A antagonists BMY 7378, NAN 190 and (−)-propranolol on serotonergic dorsal raphe unit activity in behaving cats, J. Pharmacol. Exp. Ther., 270, 1359
Fornal, 1996, WAY-100635, a potent and selective 5-hydroxytryptamine1A antagonist, increases serotonergic neuronal activity in behaving cats: comparison with (S)-WAY-100135, J. Pharmacol. Exp. Ther., 278, 752
Francis, 1992, 5-Hydroxytryptamine1A but not 5-hydroxytryptamine2 receptors are enriched on neocortical pyramidal neurones destroyed by intrastriatal volkensin, J. Pharmacol. Exp. Ther., 261, 1273
Francken, B.J.B., Jurzak, M., Luyten, W.H.M.L., et al., 1998. h5-HT5A receptor in stably transfected HEK293 cells couples to G-proteins and receptor activation inhibits adenylate cyclase. Fourth IUPHAR Satellite meeting on Serotonin, Rotterdam, pp. 66.
Froehner, 1990, The postsynaptic 43K protein clusters muscle nicotinic acetylcholine receptors in Xenopus oocytes, Neuron, 5, 403, 10.1016/0896-6273(90)90079-U
Fuller, 1996, Serotonin receptors involved in the regulation of pituitary-adrenocrtical function in rats, Behav. Brain Res., 73, 215, 10.1016/0166-4328(96)00099-X
Gaddum, 1957, Two kinds of tryptamine receptor, Br. J. Pharmacol., 12, 323
Gale, 1994, GR113 808-A novel, selective antagonist with high affinity at the 5-HT4 receptor, Br. J. Pharmacol., 111, 332, 10.1111/j.1476-5381.1994.tb14064.x
Galeotti, 1997, Antiamnesic activity of metoclopramide, cisapride and SR-17 in the mouse passive avoidance test, Pharmacol. Res., 36, 59, 10.1006/phrs.1997.0205
Galeotti, 1998, Role of 5-HT4 receptors in the mouse passive avoidance test, J. Pharmacol. Exp. Ther., 286, 1115
Galzin, 1992, Characterization of the 5-hydroxytryptamine receptor modulating the release of 5-[3H]hydroxytryptamine in slices of the human neocortex, J. Neurochem., 59, 1293, 10.1111/j.1471-4159.1992.tb08440.x
Gartside, 1990, Effects of MDL 73005EF on central pre- and postsynaptic 5-HT1A receptor function in the rat in vivo, Eur. J. Pharmacol., 191, 391, 10.1016/0014-2999(90)94173-U
Gartside, 1995, Interaction between a selective 5-HT1A receptor antagonist and an SSRI in vivo: effects on 5-HT cell firing and extracellular 5-HT, Br. J. Pharmacol., 115, 1064, 10.1111/j.1476-5381.1995.tb15919.x
Gartside, 1997, Acute effects of 3,4-methylenedioxymethamphetamine (MDMA) on 5-HT cell firing and release: comparison between dorsal and median raphe 5-HT systems, Neuropharmacology, 36, 1697, 10.1016/S0028-3908(97)00171-8
Gartside, 1997, Inhibition of 5-HT cell-firing in the DRN by antidepressant drugs: role of 5-HT1A autoreceptors and a1-adrenoceptors, Psychopharmacology, 130, 261, 10.1007/s002130050238
Ge, 1996, 5-HT4 receptor mediated modulation of 5-HT release in the rate hippocampus in vivo, Br. J. Pharmacol., 117, 1474, 10.1111/j.1476-5381.1996.tb15309.x
Gelernter, 1995, Assignment of the 5HT7 receptor gene (HTR7) to chromosome 10q and exclusion of genetic linkage with Tourette syndrome, Genomics, 26, 207, 10.1016/0888-7543(95)80202-W
Gerald, 1995, The 5-HT4 receptor: molecular cloning and pharmacological characterisation of two splice variants, EMBO J., 14, 2806, 10.1002/j.1460-2075.1995.tb07280.x
Gérald, 1996, Quantitative RT-PCR distribution of serotonin 5-HT6 receptor mRNA in the central nervous system of control or 5,5-dihydroxytryptamine-treated rats, Synapse, 23, 164, 10.1002/(SICI)1098-2396(199607)23:3<164::AID-SYN5>3.0.CO;2-6
Gérald, 1997, Immuno-localization of serotonin 5-HT6 receptor-like material in the rat central nervous system, Brain Res., 746, 207, 10.1016/S0006-8993(96)01224-3
Gerfen, 1992, The neostriatal mosaic: multiple levels of compartmental organization, Trends Neurosci., 15, 133, 10.1016/0166-2236(92)90355-C
Geyer, 1996, Serotonergic functions in arousal and motor activity, Behav. Brain Res., 73, 31, 10.1016/0166-4328(96)00065-4
Gilbert, 1988, Activation of the 5-HT1A receptor subtype increases rat plasma ACTH concentration, Eur. J. Pharmacol., 147, 431, 10.1016/0014-2999(88)90178-1
Glatt, C.E., Snowman A.M., Sibley, D.R., Snyder, S.H., 1995. Clozapine-selective labelling of sites resembling 5HT6 serotonin receptors may reflect psychoactive profile. Mol. Med. 1, 398–406.
Glennon, 1990, Do classical hallucinogens act as 5-HT2 agonists or antagonists?, Neuropsychopharmacology, 3, 509
Glennon, 1988, Behavioural models of serotonin receptor activation, 253
Gobbi, 1996, Are 5-hydroxytryptamine7 receptors involved in [3H]5-hydroxytryptamine binding to 5-hydroxytryptamine1nonA−nonB receptors in rat hypothalamus?, Mol. Pharmacol., 49, 556
Godfrey, 1988, 5-Hydroxytryptamine-stimulated inositol phospholipid hydrolysis in the mouse cortex has pharmacological characteristics compatible with mediation via 5-HT2 receptors but this response does not reflect altered 5-HT2 function after 5,7-dihydroxytryptamine lesioning or repeated antidepressant treatments, J. Neurochem., 50, 730, 10.1111/j.1471-4159.1988.tb02975.x
Godbout, 1991, The novel 5-HT2 receptor antagonist, RP 62203, selectively blocks serotoninergic but not dopaminergic induced inhibition in the rat prefrontal cortex, Eur. J. Pharmacol., 204, 97, 10.1016/0014-2999(91)90840-M
Goodwin, 1985, The pharmacology of the hypothermic response in mice to 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT), a model of presynaptic 5-HT1 function, Neuropharmacology, 24, 1187, 10.1016/0028-3908(85)90153-4
Gorea, 1991, Regulation of noradrenergic coerulean neuronal firing mediated by 5-HT2 receptors: involvement of the prepositus hypoglossal nucleus, Neuropharmacology, 30, 1309, 10.1016/0028-3908(91)90028-A
Gozlan, 1983, Identification of presynaptic serotonin autoreceptors using a new ligand: [3H]PAT, Nature, 305, 140, 10.1038/305140a0
Green, 1976, Effects of drugs on the processes regulating the functional activity of brain 5-hydroxytryptamine, Nature, 260, 487, 10.1038/260487a0
Green, 1985, The effects of drugs on serotonin-mediated behavioural models, 326
Greenshaw, 1993, Behavioural pharmacology of 5-HT3 receptor antagonists—a critical update on therapeutic potential, Trends Pharmacol. Sci., 14, 265, 10.1016/0165-6147(93)90128-7
Grailhe, 1997, The 5-HT5A receptors: localization in the CNS and increased exploratory activity in 5-HT5A knockout mice. Soc. Neurosci, Abstr., 23, 482.19
Greuel, 1992, The putative 5-HT1A receptor antagonists NAN-190 and BMY 7378 are partial agonists in the rat dorsal raphe nucleus in vitro, Eur. J. Pharmacol., 211, 211, 10.1016/0014-2999(92)90531-8
Grossman, 1993, Development of a radioligand binding assay for 5-HT4 receptors in guinea-pig and rat brain, Br. J. Pharmacol., 109, 618, 10.1111/j.1476-5381.1993.tb13617.x
Grotewiel, 1994, Regulation of serotonin2A receptors in heterologous expession systems, J. Neurochem., 63, 1255, 10.1046/j.1471-4159.1994.63041255.x
Grotewiel, 1994, m-Chlorophenylpiperazine and m-trifluoromethylphenylpiperazine are partial agonists at cloned 5-HT2A receptors expressed in fibroblasts, J. Pharm. Exp. Ther., 271, 1122
Guan, 1992, Identification of a single amino acid residue responsible for the binding of a class of beta-adrenergic receptor antagonists to 5-hydroxytryptamine1A receptors, Mol. Pharmacol., 41, 695
Gudelsky, 1986, Thermoregulatory responses to serotonin (5-HT) receptor stimulation in the rat: evidence for opposing roles of 5-HT2 and 5-HT1A receptors, Neuropharmacology, 25, 1307, 10.1016/0028-3908(86)90101-2
Gudermann, 1993, Human S31 serotonin receptor clone encodes a 5-hydroxytryptamine1E-like serotonin receptor, Mol. Pharmacol., 43, 412
Gustafson, 1996, A receptor autoradiographic and in situ hybridisation analysis of the distribution of the 5-ht7 receptor in rat brain. Br. J, Pharmacol., 117, 657
Guy, 1997, Pain behavior in 5HT3 receptor mutant mice, Soc. Neurosci. Abstr., 23, 116.7
Hagan, 1995, The role of 5-HT1D and 5-HT1A receptors in mediating 5-hydroxytryptophan induced myoclonic jerks in guinea pigs, Eur. J. Pharmacol., 294, 743, 10.1016/0014-2999(95)00627-3
Haigler, 1974, Lysergic acid diethylamide and serotonin: a comparison of the effects on serotoninergic neurons and neurons receiving a serotonergic input, J. Pharmacol. Exp. Ther., 188, 688
Hajós, 1995, Inhibition of median and dorsal raphe neurones following administration of the selective serotonin reuptake inhibitor paroxetine, Naunyn-Schmiedeberg’s Arch. Pharmacol., 351, 624, 10.1007/BF00170162
Hajós, M., Gartside, S.E., Sharp, T., et al., 1998. 5-HT1A receptor-mediated modulation of neuronal activity of the medial prefrontal cortex, Forum Eur. Neurosic. Abstr.
Hajós, M., Hajós-Korcsok, E., Sharp, T., 1999. Role of the medial prefrontal cortex in 5-HT1A receptor-induced inhibition o 5-HT neuronal activity in the rat. Br. J. Pharmacol. (in press).
Hajós-Korcsok, 1996, 8-OH-DPAT-induced release of hippocampal noradrenaline in vivo: evidence for a role of both 5-HT1A and D1 receptors, Eur. J. Pharmacol., 314, 285, 10.1016/S0014-2999(96)00560-2
Hajós-Korcsok, E., Sharp, T., 1999. Effect of 5-HT1A receptor ligands on Fos-like immunoreactivity in rat brain: evidence for activation of noradrenergic transmission. Synapse (in press).
Hajós-Korcsok, 1999, Influence of 5-HT1A receptors on central noradrenergic activity: microdialysis studies using (±)-MDL 73(005EF and its enantiomers, Neuropharmacology, 38, 299, 10.1016/S0028-3908(98)00175-0
Hamblin, 1991, Primary structure and functional characterisation of a human 5-HT1D-type serotonin receptor, Mol. Pharmacol., 40, 143
Hamblin, 1992, Molecular cloning and functional characterization of a human 5-HT1B serotonin receptor: a homologue of the rat 5-HT1B receptor with 5-HT1D-like pharmacological specificity, Biochem. Biophys. Res. Comm., 184, 752, 10.1016/0006-291X(92)90654-4
Hamblin, 1992, Distinct 5-HT1B and 5-HT1D receptors in rat: structural and pharmacological comparison of the two cloned receptors, Mol. Cell. Neurosci., 3, 578, 10.1016/1044-7431(92)90070-I
Handley, 1995, 5-Hydroxytryptamine pathways in anxiety and its treatment, Pharmacol. Ther., 66, 103, 10.1016/0163-7258(95)00004-Z
Handley, 1993, 5-HT drugs in animal models of anxiety, Psychopharmacology, 112, 13, 10.1007/BF02247358
Harder, 1996, The 5-HT1A antagonist, WAY 100635, ameliorates the cognitive impairment induced by fornix transection in the marmoset, Psychopharmacology, 127, 245
Harel-Dupas, 1991, The inhibitory effect of trifluoromethylphenylpiperazine on [3H]acetylcholine release in guinea pig hippocampal synaptosomes is mediated by a 5-hydroxytryptamine1 receptor distinct from 1A, 1B and 1C subtypes, J. Neurochem., 56, 221, 10.1111/j.1471-4159.1991.tb02584.x
Harro, 1993, CCK in animal and human research on anxiety, Trends Pharmacol. Sci., 14, 244, 10.1016/0165-6147(93)90020-K
Hartig, 1992, A subfamily of 5-HT1D receptor genes, Trends Pharmacol. Sci., 13, 152, 10.1016/0165-6147(92)90053-9
Hartig, 1996, Alignment of receptor nomenclature with the human genome: classification of 5-HT1B and 5-HT1D receptor subtypes, Trends Pharmacol. Sci., 17, 103, 10.1016/0165-6147(96)30002-3
Heidmann, 1997, Four 5-hydroxytryptamine7 (5-HT7) receptor isoforms in human and rat produced by alternative splicing: species differences due to altered intron-exon organization, J. Neurochem., 68, 1372, 10.1046/j.1471-4159.1997.68041372.x
Heidmann, 1998, Function and distribution of three rat 5-hydroxytryptamine7 (5-HT7) receptor isoforms produced by alternative splicing, Neuropharmacology, 37, 1621, 10.1016/S0028-3908(98)00070-7
Heinemann, 1991, The nicotinic receptor genes, Clin. Neuropharmacol., 14, S45, 10.1097/00002826-199114001-00007
Hen, 1992, Of mice and flies—commonalities among 5-HT receptors, Trends Pharmacol. Sci., 13, 160, 10.1016/0165-6147(92)90054-A
Hen, 1998, The role of serotonin 1A, 1B and 5A receptor subtypes in self-administration and locomotor responses to drugs of abuse, Soc. Neurosci. Abstr., 24, 567.8
Heuring, 1987, Characterization of a novel [3H]-5-hydroxytryptamine binding site subtype in bovine brain membranes, J. Neurosci., 7, 894, 10.1523/JNEUROSCI.07-03-00894.1987
Higgins, 1988, Behavioural and biochemical consequences following activation of 5HT1-like and GABA receptors in the dorsal raphe nucleus of the rat, Neuropharmacology, 27, 993, 10.1016/0028-3908(88)90058-5
Higgins, 1991, Evidence that the unilateral activation of 5-HT1D receptors in the substantia nigra of the guinea-pig elicits contralateral rotation, Br. J. Pharmacol., 102, 305, 10.1111/j.1476-5381.1991.tb12170.x
Higgins, 1991, Evidence that the amygdala is involved in the disinhibitory effects of 5-HT3-receptor antagonists, Psychopharmacology, 104, 545, 10.1007/BF02245664
Hillegaart, 1991, Effects of local application of 5-HT and 8-OH-DPAT into the dorsal and median raphe nuclei on core temperature in the rat, Psychopharmacology, 103, 291, 10.1007/BF02244281
Hillver, 1990, (S)-5-fluoro-8-hydroxy-2-(dipropylamino)tetralin: a putative 5-HT1A-receptor antagonist, J. Med. Chem., 33, 1541, 10.1021/jm00168a002
Hirst, 1997, Identification of 5-hydroxytryptamine receptors positively coupled to adenylyl cyclase in rat cultured astrocytes, Br. J. Pharmacol., 120, 509, 10.1038/sj.bjp.0700921
Hjorth, 1993, Serotonin 5-HT1A autoreceptor blockade potentiates the ability of the 5-HT reuptake inhibitor citalopram to increase nerve terminal output of 5-HT in vivo: a microdialysis study, J. Neurochem., 60, 776, 10.1111/j.1471-4159.1993.tb03217.x
Hjorth, 1995, Studies on the role of 5-HT1A autoreceptors and alpha1-adrenoceptors in the inhibition of 5-HT release I. BMY7378 and prazosin, Neuropharmacology, 34, 615, 10.1016/0028-3908(95)00038-8
Hjorth, 1982, 8-Hydroxy-2-(di-n-propylamino)tetralin, 8-OH-DPAT, a potent and selective simplifies ergot congener with central 5-HT receptor stimulating activity, J. Neural. Transm., 55, 169, 10.1007/BF01276574
Hjorth, 1990, Mixed agonist/antagonist properties of NAN-190 at 5-HT1A receptors: behavioural and in vivo brain microdialysis studies, Life Sci., 46, 955, 10.1016/0024-3205(90)90097-B
Hjorth, 1993, In vivo microdialysis evidence for central serotonin1A and serotonin1B autoreceptor blocking properties of the beta adrenoceptor antagonist (−)penbutolol, J. Pharmacol. Exp. Ther., 265, 707
Hjorth, 1991, The putative 5-HT1B receptor agonist CP-93129 suppresses rat hippocampal 5-HT release in vivo: comparison with RU 24969, Eur. J. Pharmacol., 209, 249, 10.1016/0014-2999(91)90177-R
Hoffman, 1989, Distribution of serotonin 5-HT1C receptor mRNA in adult rat brain, FEBS Lett., 247, 453, 10.1016/0014-5793(89)81390-0
Hope, 1993, Cloning and functional expression of an apparent splice variant of the murine 5-HT3 receptor A subunit, Eur. J. Pharmacol., 245, 187, 10.1016/0922-4106(93)90128-V
Hovius, 1998, Characterization of a mouse serotonin 5-HT3 receptor purified from mammalian cells, J. Neurochem., 70, 824, 10.1046/j.1471-4159.1998.70020824.x
Hoyer, 1993, Partial agonists, full agonists, antagonists: dilemmas of definition, Trends Pharmacol. Sci., 14, 270, 10.1016/0165-6147(93)90129-8
Hoyer, 1997, 5-HT receptor-classification and nomenclature: towards harmonization with the human genome, Neuropharmacology, 36, 419, 10.1016/S0028-3908(97)00036-1
Hoyer, 1989, The pharmacology of the terminal 5-HT autoreceptors in mammalian brain: evidence for species differences, Trends Pharmacol. Sci., 10, 130, 10.1016/0165-6147(89)90159-4
Hoyer, 1986, Serotonin receptors in the human brain. I. Characterisation and autoradiographic localisation of 5-HT1A recognition sites, apparent absence of 5-HT1B recognition sites, Brain Res., 376, 85, 10.1016/0006-8993(86)90902-9
Hoyer, 1985, Characterisation of the 5-HT1B recognition site in rat brain: binding studies with [125I]iodocyanopindolol, Eur. J. Pharmacol., 118, 1, 10.1016/0014-2999(85)90657-0
Hoyer, 1985, Molecular pharmacology of 5-HT1 and 5-HT2 recognition sites in rat and pig brain membranes: radioligand binding studies with [3H]5-HT, [3H]8-OH-DPAT, (-)[125I]iodo-cyanopindolol, [3H]mesulergine and [3H]ketanserin, Eur. J. Pharmacol., 118, 13, 10.1016/0014-2999(85)90658-2
Hoyer, 1994, International union of pharmacological classification of receptors for 5-hydroxytryptamine (serotonin), Pharmacol. Rev., 46, 157
Humphrey, 1993, A proposed new nomenclature for 5-HT receptors, Trends Pharmacol. Sci., 14, 233, 10.1016/0165-6147(93)90016-D
Hussy, 1994, Functional properties of a cloned 5-hydroxytryptamine ionotropic receptor subunit: comparison with native mouse receptors, J. Physiol., 481, 311, 10.1113/jphysiol.1994.sp020441
Hutson, P.H., Bristow, L.J., Cunningham, J.R., et al., 1995. The effects of GR127935, a putative 5-HT1D receptor antagonist, on brain 5-HT metabolism, extracellular 5-HT concentration and behaviour in the guinea pig. Neuropharmacology, 34, 383–392.
Imperato, 1989, 5-HT3 receptors control dopamine release in the nucleus accumbens of freely moving rats, Neurosci. Lett., 101, 214, 10.1016/0304-3940(89)90533-8
Invernizzi, 1992, Citalopram’s ability to increase the extracellular concentrations of serotonin in the dorsal raphe prevents the drug's effect in the frontal cortex, Brain Res., 584, 322, 10.1016/0006-8993(92)90914-U
Isenberg, 1993, Partial cDNA cloning and NGF regulation of a rat 5-HT3 receptor subunit, NeuroReport, 5, 121, 10.1097/00001756-199311180-00006
Ito, 1998, PET imaging of central 5-HT2A receptors with carbon-11-MDL 100 907, J. Nucl. Med., 39, 208
Izumi, 1994, Hippocampal serotonin 5-HT1A receptor enhances acetylcholine release in conscious rats, J. Neurochem., 62, 1804, 10.1046/j.1471-4159.1994.62051804.x
Jackson, 1995, The 5-HT3 receptor channel, Ann. Rev. Physiol., 57, 447, 10.1146/annurev.ph.57.030195.002311
Jakeman, 1994, Quantitative autoradiography of 5-HT4 receptors in brains of three species using two structurally distinct radioligands, [3H]GR11 3808 and [3H]BIMU-1, Neuropharmacology, 33, 1027, 10.1016/0028-3908(94)90162-7
Jasper, 1997, Cloning, expression and pharmacology of a truncated splice variant of the human 5-HT7 receptor (h5-HT7(b)), Br. J. Pharmacol., 122, 126, 10.1038/sj.bjp.0701336
Jenck, 1993, Evidence for a role of 5-HT1C receptors in the antiserotonergic properties of some antidepressant drugs, Eur. J. Pharmacol., 231, 223, 10.1016/0014-2999(93)90453-O
Jin, 1992, Characterisation of the human 5-hydroxytryptamine1B receptor, J. Biol. Chem., 267, 5735, 10.1016/S0021-9258(18)42612-9
Johansson, 1997, The pharmacological characterization of a novel selective 5-hydroxytryptamine1A receptor antagonist, NAD-299, J. Pharmacol. Exp. Ther., 283, 216
Johnson, 1992, Cloning and expression of the rat 5-HT3 receptor reveals species-specific sensitivity to curare antagonism, Soc. Neurosci. Abstr., 18, 249
Johnson, 1993, 5-HT3 receptor ligands lack modulatory influence on acetylcholine release in rat entorhinal cortex, Naunyn-Schmiedberg’s Arch. Pharmacol., 347, 241, 10.1007/BF00167441
Johnson, 1992, 5-hydroxytryptamine1B receptors block the GABAB synaptic potential in rat dopamine neurons, J. Neurosci., 12, 2000, 10.1523/JNEUROSCI.12-05-02000.1992
Johnson, 1997, 5-HT1F receptor agonists inhibit neurogenic dural inflammation in guinea pigs, NeuroReport, 8, 2237, 10.1097/00001756-199707070-00029
Jolas, 1995, Are postsynaptic 5-HT1A receptors involved in the anxiolytic effects of 5-HT1A receptor agonists and in their inhibitory effects on the firing of serotonergic neurons in the rat?, J. Pharmacol. Exp. Ther., 272, 920
Jones, 1988, The potential anxiolytic activity of GR38032F, a 5-HT3 receptor antagonist, Br. J. Pharmacol., 93, 985, 10.1111/j.1476-5381.1988.tb11489.x
Jones, 1994, Single channel properties of the 5-HT3 subtype of serotonin receptor in primary cultures of rodent hippocampus, Neurosci. Lett., 174, 133, 10.1016/0304-3940(94)90004-3
Julius, 1990, The 5-HT2 receptor defines a family of structurally distinct but functionally conserved serotonin receptors, Proc. Natl. Acad. Sci. USA, 87, 928, 10.1073/pnas.87.3.928
Julius, 1988, Molecular characterisation of a functional cDNA encoding the serotonin1C receptor, Science, 244, 558, 10.1126/science.3399891
Kalkman, 1995, RU 24969-induced locomotion in rats is mediated by 5-HT1A receptors, Naunyn-Schmiedeberg’s Arch. Pharmacol., 352, 583, 10.1007/BF00169395
Kaufman, 1995, Serotonin 5-HT2C receptor stimulates cyclic GMP formation in choroid plexus, J. Neurochem., 64, 199, 10.1046/j.1471-4159.1995.64010199.x
Kaumann, 1994, Variable participation of 5-HT1-like receptors and 5-HT2 receptors in serotonin-induced contraction of human isolated coronary arteries, Circulation, 90, 1141, 10.1161/01.CIR.90.3.1141
Kawa, 1994, Distribution and functional properties of 5-HT3 receptors in the rat hippocampal dentate gyrus: a patch-clamp study, J. Neurophysiol., 71, 1935, 10.1152/jn.1994.71.5.1935
Kawaguchi, 1995, Striatal interneurones: chemical, physiological and morphological characterisation, Trends Neurosci., 18, 527, 10.1016/0166-2236(95)98374-8
Kehne, 1996, Preclinical characterization of the potential of the putative atypical antipsychotic MDL 100907 as a potent 5-HT2A antagonist with a favorable CNS safety profile, J. Pharmacol. Exp. Ther., 277, 968
Kelly, 1990, NaF and guanine nucleotides modulate adenylate cyclase activity in NG108-15 cells by interacting with both Gs and Gi, Br. J. Pharmacol., 100, 223, 10.1111/j.1476-5381.1990.tb15786.x
Kennett, 1991, Potencies of antagonists indicate that 5-HT1C receptors mediate 1-3(chlorophenyl)piperazine-induced hypophagia, Br. J. Pharmacol., 103, 2016, 10.1111/j.1476-5381.1991.tb12369.x
Kennett, 1994, In vivo properties of SB 200646A, a 5-HT2C/2B receptor antgonist, Br. J. Pharmacol., 111, 797, 10.1111/j.1476-5381.1994.tb14808.x
Kennett, 1996, Effects of the 5-HT2B receptor agonist, BW 723C86, on three rat models of anxiety, Br. J. Pharmacol., 117, 1443, 10.1111/j.1476-5381.1996.tb15304.x
Kennett, 1996, In vitro and in vivo profile of SB 206553, a potent 5-HT2C/5-HT2B receptor antagonist with anxiolytic-like properties, Br. J. Pharmacol., 117, 427, 10.1111/j.1476-5381.1996.tb15208.x
Kennett, 1997, SB 242084, a selective and brain penetrant 5-HT2C receptor antagonist, Neuropharmacology, 36, 609, 10.1016/S0028-3908(97)00038-5
Kennett, 1997, Anxiolytic-like actions of the selective 5-HT4 receptor antagonists, SB204070A and SB207266A in rats, Neuropharmacology, 4/5, 707, 10.1016/S0028-3908(97)00037-3
Khawaja, 1995, Quantitative autoradiographic characterisation of the binding of [3H]WAY-100 635, a selective 5-HT1A receptor antagonist, Brain Res., 673, 217, 10.1016/0006-8993(94)01416-F
Kia, 1996, Serotonin 5-HT1A receptors expressed by a subpopulation of cholinergic neurons in the rat medial septum and diagonal band of Broca—a double immunocytochemical study, Neuroscience, 74, 143, 10.1016/0306-4522(96)00087-5
Kia, 1996, Ultrastructural localization of 5-hydroxytryptamine1A receptors in rat brain, J. Neurosci. Res., 46, 697, 10.1002/(SICI)1097-4547(19961215)46:6<697::AID-JNR7>3.0.CO;2-A
Kilbinger, 1995, Benzimidazolones and renzapride facilitate acetylcholine release from guinea-pig myenteric plexus via 5-HT4 receptors, Naunyn-Schmiedeberg’s Arch. Pharmacol., 351, 229, 10.1007/BF00233241
Kilpatrick, 1991, The pharmacological characterisation of 5-HT3 receptor binding sites in rabbit ileum: comparison with those in rat ileum and rat brain, Neurochem. Int., 19, 389, 10.1016/0197-0186(91)90055-I
Kilpatrick, 1992, Inter-species variants of the 5-HT3 receptor, Biochem. Soc. Trans., 20, 118, 10.1042/bst0200118
Kirsch, 1991, The 93-kDa glycine receptor-associated protein binds to tubulin, J. Biol. Chem., 266, 22242, 10.1016/S0021-9258(18)54560-9
Kobilka, 1987, An intronless gene encoding a potential member of the family of receptors coupled to guanine nucleotide regulatory proteins, Nature, 329, 75, 10.1038/329075a0
Koek, 1992, Behavioural pharmacology of antagonists at 5-HT2/5-HT1C receptors, Neurosci. Biobehav. Rev., 16, 95, 10.1016/S0149-7634(05)80056-9
Kohen, 1996, Cloning, characterisation, and chromosomal localization of a human 5-HT6 serotonin receptor, J. Neurochem., 66, 47, 10.1046/j.1471-4159.1996.66010047.x
Koulu, 1989, Effects of acute GR38032F (ondansetron), a 5-HT3 receptor antagonist on dopamine and serotonin metabolism in mesolimbic and nigrostriatal dopaminergic neurons, Eur. J. Pharmacol., 169, 321, 10.1016/0014-2999(89)90031-9
Kung, 1995, 4-(2′-Methoxy-phenyl)-1-[2′-(n-2′′-pyridinyl)-p-iodobenzamido]-ethyl-piperazine ([125I]p-MPPI) as a new selective radioligand of serotonin1A sites in rat brain: in vitro binding and autoradiographic studies, J. Pharmacol. Exp. Ther., 272, 429
Kursar, 1994, Molecular cloning, functional expression, and mRNA distribution of the human 5-hydroxytryptamine2B receptor, Mol. Pharmacol., 46, 227
Kursar, 1992, Molecular cloning, functional expression, and pharmacological characterization of a novel serotonin receptor (5-hydroxytryptamine2f) from rat stomach fundus, Mol. Pharmacol., 42, 549
Labrecque, 1995, Serotonergic antagonists differentially inhibit spontaneous activity and decrease ligand binding capacity of the rat 5-hydroxytryptamine type 2C receptor in Sf9 cells, Mol. Pharmacol., 48, 150
Lambert, 1990, Steroid modulation of the GABAA receptor complex: electrophysiological studies, 56
Lanfumey, 1993, Further assessment of the antagonist properties of the novel and selective 5-HT1A receptor ligands (+)-WAY 100135 and SDZ 216525, Eur. J. Pharmacol., 249, 25, 10.1016/0014-2999(93)90658-5
Lankiewicz, 1998, Molecular cloning, functional expression, and pharmacological characterisation of 5-hydroxytryptamine3 receptor cDNA and its splice variants from guinea pig, Mol. Pharmacol., 53, 202, 10.1124/mol.53.2.202
Laporte, 1994, Selective in vivo labelling of brain 5-HT1A receptors by [3H]WAY 100 635 in the mouse, Eur. J. Pharmacol., 271, 505, 10.1016/0014-2999(94)90812-5
Larkman, 1991, Pharmacological characterization of the receptor mediating 5-HT evoked motoneuronal depolarization in vitro, 310
Lawrence, 1992, Terminal autoreceptor control of 5-hydroxytryptamine release as measured by in vivo microdialysis in the conscious guinea-pig, J. Neurochem., 58, 142, 10.1111/j.1471-4159.1992.tb09289.x
Le Corre, 1997, Increase of 5-HT7 (serotonin-7) and 5-HT1A (serotonin-1A) receptor mRNA expression in rat hippocampus after adrenalectomy, Psychopharmacology, 130, 368, 10.1007/s002130050252
Leonhardt, 1989, Detection of a novel serotonin receptor subtype (5-HT1E) in human brain: interaction with a GTP-binding protein, J. Neurochem., 53, 465, 10.1111/j.1471-4159.1989.tb07357.x
Letty, 1997, 5-HT4 receptors improve social olfactory memory in rat, Neuropharmacology, 4/5, 681, 10.1016/S0028-3908(96)00169-4
Levy, 1992, Molecular cloning of a human gene (S31) encoding a novel serotonin receptor mediating inhibition of adenylyl cyclase, FEBS Lett., 296, 201, 10.1016/0014-5793(92)80379-U
Levy, 1992, Molecular cloning of a human serotonin receptor (S12) with a pharmacological profile resembling that of the 5-HT1D subtype, J. Biol. Chem., 267, 7553, 10.1016/S0021-9258(18)42552-5
Leysen, 1993, Interaction of anti-psychotic drugs with neurotransmitter receptor sites in vitro and in vivo in relation to pharmacology and clinical effects-role of 5-HT2 receptors, Psychopharmacology, 112, S40, 10.1007/BF02245006
Limberger, 1991, Species differences in presynaptic serotonin autoreceptors: mainly 5-HT1B but possibly in addition 5-HT1D in the rat, 5-HT1D in the rabbit and guinea-pig brain cortex, Naunyn-Schmiedeberg’s Arch. Pharmacol., 343, 353, 10.1007/BF00179039
López-Giménez, 1997, Selective visulaisation of rat brain 5-HT2A receptors by autoradiography with [3H]MDL 100 907, Naunyn-Schmeideberg’s Arch. Pharmacol., 356, 446, 10.1007/PL00005075
Loric, 1992, New mouse 5-HT2-like receptor: expression in brain, heart and intestine, FEBS Lett., 312, 203, 10.1016/0014-5793(92)80936-B
Lovinger, 1989, Ethanol inhibits NMDA-activated ion current in hippocampal neurons, Science, 243, 1721, 10.1126/science.2467382
Lovenberg, 1993, A novel adenylyl cyclase-activating serotonin receptor (5-HT7) implicated in the regulation of mammalian circadian rhythms, Neuron, 11, 449, 10.1016/0896-6273(93)90149-L
Lovenberg, 1993, Molecular cloning and functional expression of 5-HT1E-like rat and human 5-hydroxytryptamine receptor genes, Proc. Natl. Acad. Sci., 90, 2184, 10.1073/pnas.90.6.2184
Lovinger, 1993, Trichloroethanol potentiation of 5-hydroxytryptamine3 receptor-mediated ion current in nodose ganglion neurons from the adult rat, J. Pharm. Exp. Ther., 265, 771
Lubbert, 1987, cDNA cloning of a serotonin 5-HT1C receptor by electrophysiological assays of mRNA-injected Xenopus oocytes, Proc. Natl. Acad. Sci. USA, 84, 4332, 10.1073/pnas.84.12.4332
Lucaites, 1996, Autoradiographic localisation of the serotonin1F (5-HT1F) receptor in rat brain using [3H]LY334 370, a selective 5-HT1F receptor radioligand, Soc. Neurosci. Abstr., 22, 528
Lucki, 1992, 5-HT1 receptors and behaviour, Neurosci. Biobehav. Rev., 16, 83, 10.1016/S0149-7634(05)80055-7
Lundkvist, 1996, [11C]MDL 100907, a radioligland for selective imaging of 5-HT(2A) receptors with positron emission tomography, Life Sci., 158, 187, 10.1016/0024-3205(96)00013-6
Lyer, 1996, Serotonin-mediated increase in prefrontal cortex dopamine release: pharmacological characterization, J. Pharm. Exp. Ther., 277, 40
Maeda, 1994, Inhibitory influence via 5-HT3 receptors in the induction of LTP in mossy fibre-CA3 system of guinea-pig hippocampal slices, Neurosci. Res., 18, 277, 10.1016/0168-0102(94)90163-5
Marchetti-Gauthier, 1997, BIMU1 increases associative memory in rats by activating 5-HT4 receptors, Neuropharmacology, 4/5, 697, 10.1016/S0028-3908(97)00058-0
Marek, 1994, Excitation of interneurons in piriform cortex by 5-hydroxytryptamine: blockade by MDL 100 907, a highly selective 5-HT2A receptor antagonist, Eur. J. Pharmacol., 259, 137, 10.1016/0014-2999(94)90502-9
Marek, 1996, LSD and the phenethylamine hallucinogen DOI are potent partial agonists at 5-HT2A receptors on interneurons in rat piriform cortex, J. Pharmacol. Exp. Ther., 278, 1373
Maricq, 1991, Primary structure and functional expression of the 5-HT3 receptor, a serotonin-gated ion channel, Science, 254, 432, 10.1126/science.1718042
Markstein, 1986, 5-HT1A-receptors mediate stimulation of adenylate cyclase in rat hippocampus, Naunyn-Schmiedeberg’s Arch. Pharmacol., 333, 335, 10.1007/BF00500006
Maroteaux, 1992, Mouse 5HT1B serotonin receptor: cloning, functional expression, and localization in motor control centers, Proc. Natl. Acad. Sci., 89, 3020, 10.1073/pnas.89.7.3020
Martin, 1992, Opposing roles for 5-HT1B and 5-HT3 receptors in the control of 5-HT release in rat hippocampus in vivo, Br. J. Pharmacol., 106, 139, 10.1111/j.1476-5381.1992.tb14306.x
Maura, 1992, 5-Hydroxytryptamine(3) receptors sited on cholinergic axon terminals of human cerebral cortex mediate inhibition of acetylcholine release, J. Neurochem., 58, 2334, 10.1111/j.1471-4159.1992.tb10983.x
Maura, 1998, Glutamate release in human cerebral cortex and its modulation by 5-hydroxytryptamine acting at h5-HT1D receptors, Br. J. Pharmacol., 123, 45, 10.1038/sj.bjp.0701581
Maura, 1986, Cholinergic terminals in rat hippocampus possess 5-HT1B receptors mediating inhibition of acetylcholine release, Eur. J. Pharmacol., 129, 333, 10.1016/0014-2999(86)90443-7
Maura, 1996, Serotonin 5-HT1D and 5-HT1A receptors respectively mediate inhibition of glutamate release and inhibition of cyclic GMP production in rat cerebellum in vitro, J. Neurochem., 66, 203, 10.1046/j.1471-4159.1996.66010203.x
Maura, 1993, Release-regulating serotonin 5-HT1D autoreceptors in human cerebral cortex, J. Neurochem., 60, 1179, 10.1111/j.1471-4159.1993.tb03274.x
Matthes, 1993, Mouse 5-hydroxytryptamine5A and 5-hydroxytryptamine5B receptors define a new family of serotonin receptors: cloning, functional expression, and chromosomal localization, Mol. Pharmacol., 43, 313
McAllister, 1992, Molecular cloning of a serotonin receptor from human brain (5-HT1E): a fifth 5-HT1-like subtype, Proc. Natl. Acad. Sci. USA, 89, 5517, 10.1073/pnas.89.12.5517
McAskill, 1998, Pindolol augmentation of antidepressant therapy, Br. J. Psychiatry, 173, 203, 10.1192/bjp.173.3.203
McCallum R.W., Parkash, C., Campoli-Richards, D.M., Goa, K.L. (1988) Cisapride: a preliminary review ofits pharmacodynamic and pharmcokinetic properties, and therapeutic use as a prokinetic agent in gastrointestinal disorders. Drugs, 36, 652–681.
McQuade R., Sharp T., 1996. Effect of 8-OH-DPAT on 5-HT release in dorsal and median raphe innervated brain regions of the rat. In: Gonzalez, J.L., Borges, R., Mas, M. (Eds.), Monitoring molecules in neuroscience, Proceedings of the 7th International Conference on In vivo Methods. University of Laguna, Tenerife, pp.133–134.
Medanic, 1992, Serotonin regulates the phase of the rat suprachiasmatic circadian pacemaker in vitro only during the subjective day, J. Physiol., 450, 629, 10.1113/jphysiol.1992.sp019147
Meller, 1990, Receptor reserve for 5-hydroxytryptamine1A-mediated inhibition of serotonin synthesis: possible relationship to anxiolytic properties of 5-hydroxytryptamine1A agonists, Mol. Pharmacol., 37, 231
Meller, 1990, Receptor reserve for 5-HT1A-mediated inhibition of serotonin synthesis: possible relationship to anxiolytic properties of 5-HT1A agonists, Mol. Pharmacol., 37, 231
Meller, 1997, 5-HT2A receptor induced release of glutamate from C6 glioma cells, The Pharmacologist, 39, 61
Meneses, 1997, Effects of 5-HT4 receptor agonists and antagonists in learning, Pharmacol. Biochem. Behav., 56, 347, 10.1016/S0091-3057(96)00224-9
Mengod, 1990, Localization of the mRNA for the 5-HT2 receptor by in situ hybridization histochemistry. Correlation with the distribution of receptor sites, Brain Res., 524, 139, 10.1016/0006-8993(90)90502-3
Mengod, 1990, The distribution and cellular localization of the serotonin1C receptor mRNA in the rodent brain examined by in situ hybridization histochemistry. Comparison with receptor binding distribution, Neuroscience, 35, 577, 10.1016/0306-4522(90)90330-7
Mengod, 1996, 5-HT receptors in mammalian brain: receptor autoradiography and in situ hybridisation studies of new ligands and newly identified receptors, Histochem. J., 28, 747, 10.1007/BF02272148
Metcalf, 1992, Conversion of the human 5-HT1D beta serotonin receptor to the rat 5-HT1B ligand-binding phenotype by Thr355Asn site directed mutagenesis, Biochem. Pharmacol., 44, 1917, 10.1016/0006-2952(92)90092-W
Meyerhof, 1993, A novel serotonin receptor: primary structure, pharmacology, and expression pattern in distinct brain regions, DNA Cell Biol., 12, 401, 10.1089/dna.1993.12.401
Middlemiss, 1984, Stereoselective blockade at the [3H]5-HT binding sites and at the 5-HT autoreceptor by propranool, Eur. J. Pharmacol., 101, 289, 10.1016/0014-2999(84)90173-0
Middlemiss, 1983, 8-Hydroxy-2-(di-n-propylamino)-tetralin discriminates between subtypes of the 5-HT1 recognition site, Eur. J. Pharmacol., 90, 151, 10.1016/0014-2999(83)90230-3
Middlemiss, 1990, The 5-HT1B receptors, Ann. N.Y. Acad. Sci., 600, 132, 10.1111/j.1749-6632.1990.tb16878.x
Middlemiss, 1992, Centrally active 5-HT receptor agonists and antagonists, Neurosci. Biobehav. Rev., 16, 75, 10.1016/S0149-7634(05)80054-5
Millan, 1991, 5-hydroxytryptamine (5-HT)1A receptors and the tail-flick response. I. 8-hydroxy-2-(di-n-propylamino) tetralin HBr-induced spontaneous tail-flicks in the rat as an in vivo model of 5-HT1A receptor-mediated activity, J. Pharmacol. Exp. Ther., 256, 973
Millan, 1998, Serotonin (5-HT)2C receptors tonically inhibit dopamine (DA) and noradrenaline (NA), but not 5-HT, release in the frontal cortex invivo, Neuropharmacology, 37, 953, 10.1016/S0028-3908(98)00078-1
Millan, 1997, 8-OH-DPAT-induced spontaneous tail-flicks in the rat are facilitated by the selective serotonin (5-HT)2C agonist, RO 60-0175: blockade of its actions by the novel 5-HT2C receptor antagonist SB 206 553, Neuropharmacology, 36, 743, 10.1016/S0028-3908(97)00071-3
Millan, 1993, Induction of hypothermia as a model of 5-hydroxytryptamine1A receptor-mediated activity in the rat: a pharmacological characterization of the actions of novel agonists and antagonists, J. Pharmacol. Exp. Ther., 264, 1364
Miller, 1996, New insights into the mammalian circadian clock, Sleep, 19, 641, 10.1093/sleep/19.8.641
Miller, 1992, Quantitative autoradiography of 5-CT sensitive (5-HT1D) and 5-CT insensitive (5-HT1E) serotonin receptors in human brain, Neurosci. Lett., 136, 223, 10.1016/0304-3940(92)90054-B
Milligan, 1996, G16 as a universal G-protein adapter: implications for agonist screening strategies, Trends Pharmacol. Sci., 17, 235, 10.1016/0165-6147(96)10026-2
Minabe, 1991, The 5-HT3 receptor antagonists LY 277 359 and granisetron potentiate the suppressant action of apomorphine on the basal firing rate of ventral tegmental dopamine cells, Eur. J. Pharmacol., 209, 143, 10.1016/0014-2999(91)90162-J
Miquel, 1991, Central serotonin1A receptors: respective distributions of encoding mRNA, receptor protein and binding sites by in situ hybridisation histochemistry, radioimmunohistochemistry and autoradiographic mapping in the rat brain, Neurochem. Int., 19, 453, 10.1016/0197-0186(91)90063-J
Miquel, 1992, Effect of the selective lesion of serotoninergic neurons on the regional distribution of 5-HT1A receptor mRNA in the rat brain, Brain Res. Mol. Brain Res., 14, 357, 10.1016/0169-328X(92)90104-J
Miyake, 1995, Molecular cloning of human 5-hydroxytrypamine3 receptor: heterogeneity in distribution and function among species, Mol. Pharmacol., 48, 407
Molineaux, 1989, 5-HT1C receptor is a prominent serotonin receptor subtype in the central nervous system, Proc. Natl. Acad. Sci., 86, 6793, 10.1073/pnas.86.17.6793
Monsma, 1993, Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs, Mol. Pharmacol., 43, 320
Morales, 1996, The type 3 serotonin receptor is expressed in a subpopulation of GABAergic neurons in the rat neocortex and hippocampus, Brain Res., 731, 199, 10.1016/0006-8993(96)00557-4
Morales, 1996, Cellular and subcellular immunolocalization of the type 3 serotonin receptor in the rat central nervous system, Mol. Brain Res., 36, 251, 10.1016/0169-328X(96)88406-3
Morales, 1997, The 5-HT3 receptor is present in different subpopulations of GABAergic neurons in the rat telencephalon, J. Neurosci., 17, 3157, 10.1523/JNEUROSCI.17-09-03157.1997
Morilak, 1993, Immunocytochemical localization and description of neurons expressing serotonin2 receptors in the rat brain, Neuroscience, 54, 701, 10.1016/0306-4522(93)90241-7
Morilak, 1994, Neurons expressing 5-HT2 receptors in the rat brain: neurochemical identification of cell types by immunocytochemistry, Neuropsychopharmacology, 11, 157, 10.1038/sj.npp.1380102
Morinan, A. (1989). Effects of 5-HT3 receptor antagonists GR38032F and BRL24924, on anxiety in socially isolated rats. Br. J. Pharmacol., 97, 457p.
Mork, 1990, 5-Hydroxytryptamine receptor agonists influence calcium-stimulated adenylate cyclase activity in the cerebral cortex and hippocampus of the rat, Eur. J. Pharmacol., 175, 237, 10.1016/0014-2999(90)90560-S
Mukerji, 1996, Immunological characterization and transmembrane topology of 5-hydroxytryptamine3 receptors by functional epitope tagging, J. Neurochem., 66, 1027, 10.1046/j.1471-4159.1996.66031027.x
Mundey, 1994, Effect of the putative 5-HT1A antagonists WAY 100 135 and SDZ 216-525 on 5-HT neuronal firing in the guinea-pig dorsal raphe nucleus, Neuropharmacology, 33, 61, 10.1016/0028-3908(94)90097-3
Mundey, 1996, Effects of 8-OHDPAT and 5-HT1A antagonists WAY 100 135 and WAY 100 635, on guinea-pig behaviour and dorsal raphe 5-HT neurone firing, Br. J. Pharmacol., 117, 750, 10.1111/j.1476-5381.1996.tb15254.x
Nebigil, C., Choi, D.-S., Launay, J.-M., et al., 1998. Mouse 5-HT2B receptors mediates serotonin embryonic functions. 4th IUPHAR Satellite Meeting of the Serotonin Club, Rotterdam, Abstract S2.3.
Needleman, 1970, A general method applicable to the search for similarities in the amino acid sequence of two proteins, J. Mol. Biol., 48, 443, 10.1016/0022-2836(70)90057-4
Nelson, 1995, Cloning and expression of a 5HT7 receptor from Xenopus laevis, Recept. Channel., 3, 61
Nicoll, 1990, Functional comparison of neurotransmitter receptor subtypes in mammalian central nervous system, Physiol. Rev., 70, 513, 10.1152/physrev.1990.70.2.513
Nichols, 1996, Direct observation of serotonin 5-HT3 receptor-induced increases in calcium levels in individual brain nerve terminals, J. Neurochem., 67, 581, 10.1046/j.1471-4159.1996.67020581.x
Niemeyer, 1996, Effects of agonists on the long and short splice variants of 5-HT3 receptor stably expressed in HEK-293 cells, Br. J. Pharmacol. (Suppl.), 119, P261
Nomikos, 1992, The novel 5-HT1A receptor antagonist (S)-UH-301 prevents (R)-8-OH-DPAT-induced decrease in interstitial concentrations of serotonin in the rat hippocampus, Eur. J. Pharmacol., 216, 373, 10.1016/0014-2999(92)90433-5
North, 1989, 5-Hydroxytryptamine acts at 5-HT2 receptors to decrease potassium conductance in rat nucleus accumbens neurones, J. Physiol., 417, 1, 10.1113/jphysiol.1989.sp017786
Oberlander, 1983, Effects of a potent 5-HT agonist, RU 24 969, on the mesocortico-limbic and nigrostriatal dopamine systems, Br. J. Pharmacol., 80, 675P
Oberlander, 1981, Dopamine-independent rotational response to unilateral injection of serotonin, Life Sci., 28, 2595, 10.1016/0024-3205(81)90716-5
Obosi, 1997, Mutational analysis of the mouse 5-HT7 receptor: importance of the third intracellular loop for receptor-G-protein interaction, FEBS Lett., 412, 321, 10.1016/S0014-5793(97)00813-2
O’Connell, 1992, Evidence for postsynaptic mediation of the hypothermic effect of 5-HT1A receptor activation, Br. J. Pharmacol., 106, 603, 10.1111/j.1476-5381.1992.tb14382.x
Olivier, 1995, Serotonin receptors and animal models of aggressive behavior, Pharmacopsychiatry, 28, 80, 10.1055/s-2007-979624
Olsen, 1982, Drug interactions at the GABA receptor-ionophore complex, Ann. Rev. Pharmacol. Toxicol., 22, 245, 10.1146/annurev.pa.22.040182.001333
Ortells, 1995, Evolutionary history of the ligand-gated ion-channel superfamily of receptors, Trends Neurosci., 18, 121, 10.1016/0166-2236(95)93887-4
Oksenberg, 1992, A single amino-acid difference confers major pharmacological variation between human and rodent 5-HT1B receptors, Nature, 360, 161, 10.1038/360161a0
Overshiner, 1996, LY334370 is selective for the cloned 5-HT1F receptor, Soc. Neurosci. Abstr., 22, 528.12
Parks, 1998, Increased anxiety of mice lacking the serotonin1A receptor, Proc. Natl. Acad. Sci., 95, 10734, 10.1073/pnas.95.18.10734
Patel, 1995, Localization of serotonin-4 receptors in the striatonigral pathway in rat brain, Neuroscience, 69, 1159, 10.1016/0306-4522(95)00314-9
Palacios, 1991, Autoradiography of 5-HT receptors: a critical appraisal, Neurochem. Int., 18, 17, 10.1016/0197-0186(91)90030-H
Parker, 1996, Autoradiograpghic distribution of [3H]-(S)-zacopride-labelled 5-HT3 receptors in human brain, J. Neurolog. Sci., 144, 119, 10.1016/S0022-510X(96)00211-0
Parker, 1993, A single amino acid difference accounts for the pharmacological distinctions between the rat and human 5-hydroxytryptamine1B receptors, J. Neurochem., 60, 380, 10.1111/j.1471-4159.1993.tb05865.x
Parker, 1996, Allosteric modulation of 5-HT3 receptors: focus on alcohols and anaesthetic agents, Trends Pharmacol. Sci., 17, 95, 10.1016/0165-6147(96)10003-1
Pascual, 1996, [3H]sumatriptan binding sites in human brain: region-dependent labelling of 5-HT1D and 5-HT1F receptors, Eur. J. Pharmacol., 295, 271, 10.1016/0014-2999(95)00748-2
Passani, 1994, Effects of DAU 6125, a novel 5-hydroxytryptamine3 (5-HT3) antagonist on electrophysiological properties of the rat hippocampus, Br. J. Pharmacol., 112, 695, 10.1111/j.1476-5381.1994.tb13132.x
Paudice, 1991, Cholecystokinin release mediated by 5-HT3 receptors in rat cerebral cortex and nucleus accumbens, Br. J. Pharmacol., 103, 1790, 10.1111/j.1476-5381.1991.tb09864.x
Pauwels, 1996, Selective antagonism of human 5-HT1D and 5-HT1B receptor-mediated responses in stably transfected C6-glial cells by ketanserin and GR 127935, Eur. J. Pharmacol., 300, 141, 10.1016/0014-2999(96)00011-8
Pauwels, 1996, Pharmacology of cloned human 5-HT1D receptor-mediated functional responses in stably transfected rat C6-glial cell lines: further evidence differentiating human 5-HT1D and 5-HT1B receptors, Naunyn-Schmiedeberg’s Arch. Pharmacol., 353, 144, 10.1007/BF00168751
Pauwels, 1997, How efficacious are 5-HT1B/D receptor ligands: an answer from GTPgS binding studies with stably transfected C6-glial cell lines, Neuropharmacology, 4/5, 499, 10.1016/S0028-3908(96)00170-0
Pazos, 1985, Quantitative autoradiographic mapping of serotonin receptors in the rat brain. II. Serotonin-2 receptors, Brain Res., 346, 231, 10.1016/0006-8993(85)90857-1
Pazos, 1985, Quantitative autoradiographic mapping of serotonin receptors in the rat brain. I. Serotonin-1 receptors, Brain Res., 346, 205, 10.1016/0006-8993(85)90856-X
Pazos, 1987, Serotonin receptors in the human brain-IV. Autoradiographic mapping of serotonin-2 receptors, Neuroscience, 21, 123, 10.1016/0306-4522(87)90327-7
Pazos, 1984, The binding of serotonergic ligands to the porcine choroid plexus: characterisation of a new type of serotonin recognition site, Eur. J. Pharmacol., 106, 539, 10.1016/0014-2999(84)90057-8
Pedigo, 1981, Discrimination of multiple [3H]5-hydroxytrytamine binding sites by the neuroleptic spiperone in the rat brain, J. Neurochem., 36, 205, 10.1111/j.1471-4159.1981.tb02397.x
Peroutka, 1979, Multiple serotonin receptors: differential binding of [3H]5-hydroxytryptamine, [3H]lysergic acid diethylamide and [3H]spiroperidol, Mol. Pharmacol., 16, 687
Peters, 1992, Recent advances in the electrophysiological characterization of 5-HT3 receptors, Trends Pharmacol. Sci., 13, 391, 10.1016/0165-6147(92)90119-Q
Phebus, 1997, Characterisation of LY 344864 as a pharmacological tool to study 5-HT1F receptors: binding affinities, brain penetration and activity in the neurogenic inflammation model of migraine, Life Sci., 61, 2117, 10.1016/S0024-3205(97)00885-0
Piguet, 1994, Transient and long-lasting actions of 5-HT on rat dentate gyrus neurones in vitro, J. Physiol. Lond., 481, 629, 10.1113/jphysiol.1994.sp020469
Pike, 1995, First delineation of 5-HT1A receptors in human brain with PET and [11C]WAY-100635, Eur. J. Pharmacol., 283, R1, 10.1016/0014-2999(95)00438-Q
Piñeyro, 1995, Regulation of [3H]5-HT release in raphe, frontal cortex and hippocampus of 5-HT1B knock-out mice, NeuroReport, 7, 353, 10.1097/00001756-199512290-00084
Piñeyro, 1995, 5-HT1D receptors regulate 5-HT release in the rat raphe nuclei. In vivo voltammetry and in vitro superfusion studies, Neuropsychopharmacology, 13, 249, 10.1016/0893-133X(95)00109-Q
Piñeyro, 1996, Autoregulatory properties of dorsal raphe 5-HT neurons: possible role of electrotonic coupling and 5-HT1D receptors in the rat brain, Synapse, 22, 54, 10.1002/(SICI)1098-2396(199601)22:1<54::AID-SYN6>3.0.CO;2-H
Plassat, 1992, The mouse 5-HT5 receptor reveals a remarkable heterogeneity within the 5-HT1D receptor family, EMBO J., 11, 4779, 10.1002/j.1460-2075.1992.tb05583.x
Plassat, 1992, The mouse 5-HT5 receptor reveals a remarkable heterogeneity within the 5-HT1D receptor family, EMBO J., 11, 4779, 10.1002/j.1460-2075.1992.tb05583.x
Plassat, 1993, Molecular cloning of a mammalian serotonin receptor that activates adenylate cyclase, Mol. Pharmacol., 44, 229
Pompeiano, 1992, Distribution and cellular localization of mRNA coding for 5-HT1A receptor in rat brain: correlation with receptor binding, J. Neurosci., 12, 440, 10.1523/JNEUROSCI.12-02-00440.1992
Pompeiano, 1994, Distribution of the serotonin 5-HT2 receptor family messenger RNAs: comparison between 5-HT2A and 5-HT2C receptors, Mol. Brain Res., 23, 163, 10.1016/0169-328X(94)90223-2
Price, 1997, SB-216641 and BRL-15572-compounds to pharmacologically discriminate h5-HT1B and h5-HT1D receptors, Naunyn-Schmeideberg’s Arch. Pharmacol., 356, 312, 10.1007/PL00005056
Prisco, 1993, Tertatolol, a new beta-blocker, is a serotonin (5-hydroxytryptamine1A) receptor antagonist in rat brain, J. Pharmacol. Exp. Ther., 265, 739
Prosser, 1993, Serotonin and the mammalian circadian system: I. In vitro phase shifts by serotonergic agonists and antagonists, J. Biol. Rhythms, 8, 1, 10.1177/074873049300800101
Pratt, 1990, The distribution of 5-HT3 receptors in mammalian hindbrain—a consensus, Trends Pharmacol. Sci., 11, 135, 10.1016/0165-6147(90)90058-G
Price, 1990, Transmitter systems in selected types of dementia
Prisco, 1992, Chronic treatment with DAU 6215, a new 5-HT3 receptor antagonist, causes a selective decrease in the number of spontaneously active dopaminergic neurons in the ventral tegmental area, Eur. J. Pharmacol., 214, 13, 10.1016/0014-2999(92)90089-M
Pritchett, 1988, Structure and functional expression of a cloned rat serotonin 5-HT-2 receptor, EMBO J., 7, 4135, 10.1002/j.1460-2075.1988.tb03308.x
Pritchett, 1988, Structure and functional expression of cloned rat serotonin 5-HT2 receptor, EMBO J., 7, 4135, 10.1002/j.1460-2075.1988.tb03308.x
Prosser, 1989, The mammalian circadian clock in the suprachiasmatic nuclei is reset in vitro by cAMP, J. Neurosci., 9, 1073, 10.1523/JNEUROSCI.09-03-01073.1989
Radja, 1991, Autoradiography of serotonin receptor subtypes in the central nervous system, Neurochem. Int., 18, 1, 10.1016/0197-0186(91)90029-D
Raiteri, 1993, Inhibition by 5-HT3 receptor antagonists of release of cholecystokinin-like immunoreactivity from the frontal cortex of freely moving rats, Naunyn-Schmiedeberg’s Arch. Pharmacol., 347, 111, 10.1007/BF00168781
Ramı́rez, 1996, Involvement of GABA systems in acetylcholine release induced by 5-HT3 receptor blockade in slices from rat entorhinal cortex, Brain Res., 712, 274, 10.1016/0006-8993(95)01471-3
Reavil, 1998, 5-HT4 receptor antagonism does not affect motor and reward mechanisms in the rat, Eur. J. Pharmacol., 357, 115, 10.1016/S0014-2999(98)00564-0
Rees, 1994, Cloning and characterisation of the human 5-HT5A serotonin receptor, FEBS Lett., 355, 242, 10.1016/0014-5793(94)01209-1
Reynolds, 1995, 5-Hydroxytryptamine (5-HT)4 receptors in post mortem human brain tissue: Distribution, pharmacology and effects of neurodegenerative diseases, Br. J. Pharmacol., 114, 993, 10.1111/j.1476-5381.1995.tb13303.x
Riad, 1994, Neurotrophic effects of ipsapirone and other 5-HT1A receptor agonists on septal cholinergic neurons in culture, Brain Res. Dev. Brain Res., 82, 245, 10.1016/0165-3806(94)90167-8
Rick, 1995, Excitation of rat substantia nigra pars reticulata neurons by 5-hydroxytryptamine in vitro: evidence for a direct action mediated by 5-hydroxytryptamine2C receptors, Neuroscience, 69, 903, 10.1016/0306-4522(95)00283-O
Riekkinen, 1991, Non-reversal of scopolamine- or age-related EEG changes by ondansetron, methysergide or alaproclate, Psychopharmacology, 103, 567, 10.1007/BF02244260
Roberts, 1997, Importance of h5-HT1B receptor selectivity for 5-HT terminal autoreceptor activity: an in vivo microdialysis study in the freely moving guinea pig, Neuropharmacology, 4/5, 549, 10.1016/S0028-3908(97)00026-9
Roberts, C., Belenguer, A., Middlemiss, D.N., et al., 1997b. Comparison of 5-HT autoreceptor control in guinea pig dorsal and median raphe innervated brain regions. Br. J. Pharmacol. (in press).
Robinson, 1990, Clinical effects of the partial 5-HT1A agonists in depression: a composite analysis of buspirone in the treatment of depression, J. Clin. Psychopharmacol., 10, 67S, 10.1097/00004714-199006001-00013
Rollema, 1996, Combined administration of a 5-hydroxytryptamine (5-HT)1D antagonist and a 5-HT reuptake inhibitor synergistically increases 5-HT release in guinea pig hypothalamus in vivo, J. Neurochem., 67, 2204, 10.1046/j.1471-4159.1996.67052204.x
Romero, 1996, The 5-HT1A antagonist, WAY-100 635 selectively potentiates the presynaptic effects of serotonergic antidepressants in rat brain, Neurosci. Lett., 219, 123, 10.1016/S0304-3940(96)13199-2
Rondé, 1995, Homologous desensitization of 5-hydroxytryptamine4 receptors in rat esophagus: functional and second messenger studies, J. Pharm. Exp. Ther., 272, 977
Rondé, 1998, High calcium permeability of serotonin 5-HT3 receptors on presynaptic nerve terminals from rat striatum, J. Neurochem., 70, 1094, 10.1046/j.1471-4159.1998.70031094.x
Ropert, 1991, Serotonin facilitates GABAergic transmission in the CA1 region of rat hippocampus in vitro, J. Physiol., 441, 121, 10.1113/jphysiol.1991.sp018742
Roth, 1991, Chronic mianserin treatment decreases 5-HT2 receptor binding without altering 5-HT2 receptor mRNA levels, Eur. J. Pharmacol., 207, 169, 10.1016/0922-4106(91)90093-W
Roth, 1992, Binding of typical and atypical antipsychotic agents to transiently expressed 5-HT1C receptors, J. Pharmacol. Exp. Ther., 260, 1361
Roth, 1994, Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors, J. Pharm. Exp. Ther., 268, 1403
Routledge, 1993, Neurochemical profile of the selective and silent 5-HT1A receptor antagonist WAY 100135: an in vivo microdialysis study, Eur. J. Pharmacol., 239, 195, 10.1016/0014-2999(93)90994-S
Roychowdhury, 1994, 5-HT1A and 5-HT4 receptor colocalization on hippocampal pyramidal cells, Neuropharmacology, 33, 551, 10.1016/0028-3908(94)90086-8
Ruat, 1993, A novel rat serotonin (5-HT6) receptor: molecular cloning, localization and stimulation of cAMP accumulation, Biochem. Biophys. Res. Comm., 193, 268, 10.1006/bbrc.1993.1619
Ruat, 1993, Molecular cloning, characterization, and localization of a high-affinity serotonin receptor (5-HT7) activating cAMP formation, Proc. Natl. Acad. Sci., 90, 8547, 10.1073/pnas.90.18.8547
Saudou, 1994, Enhanced aggressive behaviour in mice lacking 5-HT1B receptor, Science, 265, 1875, 10.1126/science.8091214
Saudou, 1994, 5-Hydroxytryptamine receptor subtypes in vertebrates and invertebrates, Neurochem. Int., 25, 503, 10.1016/0197-0186(94)90150-3
Saltzman, 1991, Cloning of the human serotonin 5-HT2 and 5-HT1C receptor subtypes, Biochem. Biophys. Res. Comm., 181, 1469, 10.1016/0006-291X(91)92105-S
Sanchez, 1996, Assessment of relative eficacies of 5-HT1A receptor ligands by means of in vivo animal models, Eur. J. Pharmacol., 315, 245, 10.1016/S0014-2999(96)00621-8
Sanders-Bush, 1990, Adaptive regulation of central serotonin receptors linked to phosphoinositide hydrolysis, Neuropsychopharmacology, 3, 411
Sanders-Bush, 1988, Lysergic acid diethylamide and 2,5-dimethoxy-4-methylamphetamine are partial agonists at serotonin receptors linked to phosphoinositide hydrolysis, J. Pharmacol. Exp. Ther., 246, 924
Sanders-Bush, 1995, Serotonin receptors: signal transduction pathways, 431
Schiavi, 1994, Identification of serotonin 5-HT4 recognition sites in the porcine caudate nucleus by radioligand binding, Neuropharmacology, 33, 543, 10.1016/0028-3908(94)90085-X
Schlicker, 1997, Effects of selective 5-HT1B (SB-216 641) and 5-HT1D (BRL 15572) receptor ligands on guinea-pig and human 5-HT auto- and heteroceptors, Naunyn-Schmeideberg’s Arch. Pharmacol., 356, 321, 10.1007/PL00005057
Schmidt, 1989, The putative 5-HT3 agonist phenylbiguanide induces carrier-mediated release of [3H]dopamine, Eur. J. Pharmacol., 167, 309, 10.1016/0014-2999(89)90595-5
Schmuck, 1994, Cloning and functional characterization of the human 5-HT2B serotonin receptor, FEBS Lett., 342, 85, 10.1016/0014-5793(94)80590-3
Schoeffter, 1997, Inhibition of cAMP accumulation via recombinant human serotonin 5-HT1A receptors: considerations on receptor effector coupling across systems, Neuropharmacology, 36, 429, 10.1016/S0028-3908(97)00043-9
Schoeffter, 1988, Centrally acting hypotensive agents with affinity for 5-HT1A binding sites inhibit forskolin-stimulated adenylate cyclase activity in calf hippocampus, Br. J. Pharmacol., 95, 975, 10.1111/j.1476-5381.1988.tb11728.x
Schoeffter, 1989, 5-Hydroxytryptamine 5-HT1B and 5-HT1D receptors mediating inhibition of adenylate cyclase activity. Pharmacological comparison with special reference to the effects of yohimbine, rauwolscine and some beta-adrenoceptor antagonists, Naunyn-Schmiedeberg’s Arch. Pharmacol., 340, 285, 10.1007/BF00168512
Schoeffter, 1994, 5-Hydroxytryptamine receptors with a 5-HT6 receptor-like profile stimulating adenylyl cyclase activity in pig caudate membranes, Naunyn-Schmiedeberg’s Arch. Pharmacol., 350, 356, 10.1007/BF00178951
Schreiber, 1995, 1-(2,5-dimethoxy-4 iodophenyl)-2-aminopropane)-induced head-twitches in the rat are mediated by 5-hydroxytryptamine (5-HT)2A receptors: modulation by novel 5-HT2A/2C antagonists, D1 antagonists and 5-HT1A agonists, J. Pharmacol. Exp. Ther., 273, 101
Schreiber, 1993, Studies on the neuronal circuits involved in the discriminative stimulus effects of 5-hydroxytryptamine1A receptor agonists in the rat, J. Pharmacol. Exp. Ther., 265, 572
Sebben, 1994, 5-HT6 receptors positively coupled to adenylyl cyclase in striatal neurones in culture, NeuroReport, 5, 2553, 10.1097/00001756-199412000-00037
Segal, 1975, Physiological and pharmacological evidence for a serotonergic projection to the hippocampus, Brain. Res., 94, 115, 10.1016/0006-8993(75)90881-1
Sharp, 1990, Application of brain microdialysis to study the pharmacology of the 5-HT1A autoreceptor, J. Neurosci. Methods, 34, 83, 10.1016/0165-0270(90)90045-H
Sharp, 1989, 5-HT1 agonists reduce 5-hydroxytryptamine release in rat hippocampus in vivo as determined by brain microdialysis, Br. J. Pharmacol., 96, 283, 10.1111/j.1476-5381.1989.tb11815.x
Sharp, 1990, Further investigation of the in vivo pharmacological properties of the putative 5-HT1A antagonist, BMY 7378, Eur. J. Pharmacol., 176, 331, 10.1016/0014-2999(90)90027-4
Sharp, 1993, The novel 5-HT1A receptor antagonist, SDZ 216-525, decreases 5-HT release in rat hippocampus in vivo, Br. J. Pharmacol., 109, 699, 10.1111/j.1476-5381.1993.tb13630.x
Sharp, 1996, The role of 5-HT1A autoreceptors and alpha1-adrenoceptors in the inhibition of 5-HT release-II NAN-190 and SDZ 216-525, Neuropharmacology, 35, 735
Sharp, 1997, Effects of co-administration of an MAOI and a 5-HT1A receptor antagonist on 5-HT neuronal activity and release, Eur J. Pharmacol., 320, 15, 10.1016/S0014-2999(96)00968-5
Sharpley, 1994, Slow wave sleep in humans: role of 5-HT2A and 5-HT2C receptors, Neuropharmacology, 33, 467, 10.1016/0028-3908(94)90077-9
Sheldon, 1991, Excitatory responses to serotonin (5-HT) in neurons of the rat piriform cortex: evidence for mediation by 5-HT1C receptors in pyramidal cells and 5-HT2 receptors in interneurons, Synapse, 9, 208, 10.1002/syn.890090307
Shen, 1993, Molecular cloning and expression of a 5-hydroxytryptamine7 serotonin receptor subtype, J. Biol. Chem., 268, 18200, 10.1016/S0021-9258(17)46830-X
Shimizu, 1996, Chronic antidepressant exposure enhances 5-hydroxytryptamine7 receptor-mediated cyclic adenosine monophosphate accumulation in rat frontocortical astrocytes, J. Pharm. Exp. Ther., 279, 1551
Shenker, 1983, Enhanced serotonin-stimulated adenylate cyclase activity in membranes from adult guinea pig hippocampus, Life Sci., 32, 2335, 10.1016/0024-3205(83)90763-4
Shimizu, 1998, Agonist-induced desensitization of adenylyl cyclase activity mediated by 5-hydroxytryptamine7 receptors in rat frontocortical astrocytes, Brain Res., 784, 57, 10.1016/S0006-8993(97)01185-2
Sieghart, 1992, GABAA receptors: ligand-gated Cl− ion channels modulated by multiple drug-binding sites, Trends Pharmacol. Sci., 13, 446, 10.1016/0165-6147(92)90142-S
Silvestre, 1996, Effects of 5-HT4 receptor antagonists on rat behaviour in the elevated plus-maze test, Eur. J. Pharmacol., 309, 219, 10.1016/0014-2999(96)00457-8
Simansky, 1996, Serotonergic control of the organization of feeding and satiety, Behav. Brain Res., 73, 37, 10.1016/0166-4328(96)00066-6
Sinton, 1988, Electrophysiological evidence for a functional differentiation between subtypes of the 5-HT1 receptor, Eur. J. Pharmacol., 157, 173, 10.1016/0014-2999(88)90380-9
Skingle, 1996, GR127935: a potent and selective 5-HT1D receptor antagonist, Behav. Brain Res., 73, 157, 10.1016/0166-4328(96)00089-7
Skingle, 1995, Effects of the 5-HT1D receptor antagonist GR127935 on extracellular levels of 5-HT in the guinea-pig frontal cortex as measured by microdialysis, Neuropharmacology, 34, 377, 10.1016/0028-3908(94)00167-Q
Sleight, 1998, Characterization of Ro 04-6790 and Ro 63-0563: potent and selective antagonists at human and rat 5-HT6 receptors, Br. J. Pharmacol., 124, 556, 10.1038/sj.bjp.0701851
Sleight, 1995, Identification of 5-hydroxytryptamine7 receptor binding sites in rat hypothalamus: sensitivity to chronic antidepressant treatment, Mol. Pharmacol., 47, 99
Sleight, 1997, 5-HT6 and 5-HT7 receptors: molecular biology, functional correlates and possible therapeutic indications, Drug News and Perspectives, 10, 214
Sorensen, 1989, Effect of acute and chronic MDL 73147EF, a 5-HT3 receptor antagonist, on A9 and A10 dopamine neurons, Eur. J. Pharmacol., 163, 115, 10.1016/0014-2999(89)90402-0
Sorensen, 1993, Characterization of the 5-HT2 receptor antagonist MDL 100 907 as a putative atypical antipsychotic: behavioral, electrophysiological and neurochemical studies, J. Pharmacol. Exp. Ther., 266, 684
Sprouse, 1991, Inhibition of dorsal raphe cell firing by MDL 73 005EF, a novel 5-HT1A receptor ligand, Eur. J. Pharmacol., 201, 163, 10.1016/0014-2999(91)90340-V
Sprouse, 1988, Responses of hippocampal pyramidal cells to putative serotonin 5-HT1A and 5-HT1B agonists: a comparative study with dorsal raphe neurons, Neuropharmacology, 27, 707, 10.1016/0028-3908(88)90079-2
Stam, 1997, Human serotonin 5-HT7 receptor: cloning and pharmacological characterisation of two receptor variants, FEBS Lett., 413, 489, 10.1016/S0014-5793(97)00964-2
Stam, 1992, Genomic organization, coding sequence and functional expression of human 5-HT2 and 5-HT1A receptor genes, Eur. J. Pharmacol., 227, 153, 10.1016/0922-4106(92)90123-D
Starkey, 1994, 5-HT1D as well as 5-HT1A autoreceptors modulate 5-HT release in the guinea-pig dorsal raphe nucleus, Neuropharmacology, 33, 393, 10.1016/0028-3908(94)90069-8
Staubli, 1995, Effects of 5-HT3 receptor antagonism on hippocampal theta-rhythm, memory and LTP induction in the freely moving rat, J. Neurosci., 15, 2445, 10.1523/JNEUROSCI.15-03-02445.1995
Steward, 1993, Reduced levels of 5-HT3 receptor recognition sites in the putamen of patients with Huntington’s disease, Eur. J. Pharmacol., 242, 137, 10.1016/0014-2999(93)90073-Q
Steward, 1996, Ability of 5-HT4 receptor ligands to modulate rat striatal dopamine release in vitro and in vivo, Br. J. Pharmacol., 117, 55, 10.1111/j.1476-5381.1996.tb15154.x
Steward, 1993, Labelling of 5-HT3 receptor recognition sites in the rat brain using the agonist radioligand [3H]meta-chlorophenylbiguanide, Eur. J. Pharmacol., 243, 13, 10.1016/0014-2999(93)90161-A
Stowe, R.L., Barnes, N.M., 1998a. Selective labelling of 5-HT7 receptor recognition sites in rat brain using [3H]5-carboxamidotryptamine. Neuropharmacology 37, 1611–1619.
Stowe, 1998, Cellular distribution of 5-HT7 receptor mRNA in rat brain, Br. J. Pharmacol., 123, 229P
Sugita, 1992, 5-Hydroxytryptamine is a fast excitatory transmitter at 5-HT3 receptors in rat amygdala, Neuron, 8, 199, 10.1016/0896-6273(92)90121-S
Suzuki, 1995, Increase of noradrenaline release in the hypothalamus of freely moving rat by postsynaptic 5-hydroxytryptamine1A receptor activation, Br. J. Pharmacol., 115, 703, 10.1111/j.1476-5381.1995.tb14990.x
Tanaka, 1993, Actions of 5-hydroxytryptamine on neurons of the rat cingulate cortex, J. Neurophysiol., 69, 1749, 10.1152/jn.1993.69.5.1749
Tecott L.H., Chu H.-M., Brennan T.J., 1998. Neurobehavioural analysis of 5-HT6 receptor null mice. Fourth IUPHAR Satellite meeting on Serotonin, Rotterdam, S1.2.
Tecott, 1993, Nervous system distribution of the serotonin 5-HT3 receptor messenger RNA, Proc. Natl. Acad. Sci., 90, 1430, 10.1073/pnas.90.4.1430
Tecott, 1995, Eating disorder and epilepsy in mice lacking 5-HT2C serotonin receptors, Nature, 374, 542, 10.1038/374542a0
Terry, 1998, Enhanced delayed matching performance in younger and older macaques administered the 5-HT4 receptor agonist, RS17017, Psychopharmacology, 135, 407, 10.1007/s002130050529
Thorré, 1998, 5-HT4 receptor involvement in the serotonin-enhanced dopamine efflux from the substantia nigra of the freely moving rat: a microdialysis study, Brain Res., 796, 117, 10.1016/S0006-8993(98)00337-0
To, 1995, Characterisation and distribution of putative 5-ht7 receptors in guinea pig brain. Br. J, Pharmacol., 115, 107
Tonini, 1989, Effects of cisapride on cholinergic neurotransmission and propulsive motility in the guinea-pig ileum, Gastroenterology, 96, 1257, 10.1016/S0016-5085(89)80012-5
Tonini, 1992, 5-Hydroxytryptamine4 receptor agonists facilitate cholinergic transmission in the circular muscle of guinea-pig ileum: antagonism by tropisetron and DAU6285, Life Sci., 50, 173, 10.1016/0024-3205(92)90453-V
Traber, 1987, 5-HT1A-related anxiolytics, Trends Pharmacol. Sci., 8, 432, 10.1016/0165-6147(87)90231-8
Tricklebank, 1984, The involvement of subtypes of the 5-HT1 receptor and of catecholaminergic systems in the behavioural response to 8-hydroxy-2-(di-n-propylamino)tetralin in the rat, Eur. J. Pharmacol., 106, 271, 10.1016/0014-2999(84)90714-3
Tricklebank, 1986, Pharmacological analysis of the behavioural and thermoregulatory effects of the putative 5-HT1 receptor agonist, RU 24 969, in the rat, Neuropharmacology, 25, 877, 10.1016/0028-3908(86)90014-6
Trillat, 1997, Regulation of serotonin release in the frontal cortex and ventral hippocampus of homozyggous mice lacking 5-HT1B receptors: in vivo microdialysis studies, J. Neurochem., 69, 2019, 10.1046/j.1471-4159.1997.69052019.x
Tsou, 1994, Cloning and expression of a 5-hydroxytryptamine7 receptor positively coupled to adenylyl cyclase, J. Neurochem., 63, 456, 10.1046/j.1471-4159.1994.63020456.x
Turek, 1985, Circadian neural rhythms in mammals, Ann. Rev. Physiol., 47, 49, 10.1146/annurev.ph.47.030185.000405
Uetz, 1994, Organisation of the murine 5-HT3 receptor gene and assignment to human chromosome 11, FEBS Lett., 339, 302, 10.1016/0014-5793(94)80435-4
Ullmer, 1996, Distribution of 5-HT4 receptor mRNA in the rat brain, Naunyn-Schmiedeberg’s Arch. Pharmacol., 354, 210, 10.1007/BF00178723
Unsworth, 1993, Characterisation of a 5-hydroxytryptamine receptor in mouse neuroblastoma N18TG2 cells, J. Pharm. Exp. Ther., 269, 246
Unwin, 1993, Nicotinic acetylcholine receptor at 9A resolution, J. Mol. Biol., 229, 1101, 10.1006/jmbi.1993.1107
Unwin, 1995, Acetylcholine receptor channel imaged in the open state, Nature, 373, 37, 10.1038/373037a0
Vaidya, 1997, 5-HT2A receptor-mediated regulation of brain-derived neurotrophic factor mRNA in the hippocampus and the neocortex, J. Neurosci., 17, 2785, 10.1523/JNEUROSCI.17-08-02785.1997
Van de Kar, 1996, Serotonergic regulation of renin and prolactin secretion, Behav. Brain Res., 73, 203, 10.1016/0166-4328(96)00097-6
Van den Hooff, 1991, Electrophysiology of the 5-HT1A ligand MDL 73005EF in the rat hippocampal slice, Eur. J. Pharmacol., 196, 291, 10.1016/0014-2999(91)90442-S
Van den Hooff, 1992, Actions of 5-hydroxytryptamine and 5-HT1A receptor ligands on rat dorso-lateral septal neurones in vitro, Br. J. Pharmacol., 106, 893, 10.1111/j.1476-5381.1992.tb14431.x
Van den Wyngaert, 1997, Cloning and expression of a human serotonin 5-HT4 receptor cDNA, J. Neurochem., 69, 1810, 10.1046/j.1471-4159.1997.69051810.x
VanderMaelen, C.P., Braselton, J.P., 1990. Intravenously administered buspirone inhibits dorsal and median raphe 5-HT neurones with about equal potency. 2nd IUPHAR Satellite Meeting on Serotonin, Basel, Switzerland.
Vane, 1959, The relative activities of some tryptamine analogues on the isolated rat stomach strip preparation, Br. J. Pharmacol. Chemother., 14, 87, 10.1111/j.1476-5381.1959.tb00933.x
Van Hooft, 1998, Promiscuous coassembly of serotonin 5-HT3 and nicotinic α4 receptor subunits into Ca2+ permeable ion channels, Proc. Natl. Acad. Sci., 95, 11456, 10.1073/pnas.95.19.11456
Van Hooft, 1995, Phosphorylation controls conductance of 5-HT3 receptor ligand-gated ion channels, Recept. Channel., 3, 7
Vanhoutte, 1996, Recommendations for nomenclature of new receptor subtypes, Pharmacol. Rev., 48, 1
Verge, 1986, Quantitative autoradiography of multiple 5-HT1 receptor subtypes in the brain of control or 5,7-dihydroxytryptamine-treated rats, J. Neurosci., 6, 3473, 10.1523/JNEUROSCI.06-12-03474.1986
Verlinden, 1988, Safety profile of cisapride, 130
Vilaró, 1996, Localization of 5-HT4 receptor mRNA in rat brain by in situ hybridisation histochemistry, Mol. Brain Res., 43, 356, 10.1016/S0169-328X(96)00248-3
Voigt, 1991, Molecular cloning and characterization of a rat brain cDNA encoding a 5-hydroxytryptamine1B receptor, EMBO J., 10, 4017, 10.1002/j.1460-2075.1991.tb04977.x
von Hungren, 1975, Serotonin-sensitive adenylate cyclase activity in immature rat brain, Brain Res., 84, 257, 10.1016/0006-8993(75)90980-4
Waeber, 1989, 5-Hydroxytryptamine3 receptors in the human brain: autoradiographic visualization using [3H]ICS205-930, Neuroscience, 31, 393, 10.1016/0306-4522(89)90382-5
Waeber, 1995, Autoradiographic visualisation of [3H]5-carboxamidotryptamine binding sites in the guinea pig and rat brain, Eur. J. Pharmacol., 283, 31, 10.1016/0014-2999(95)00275-P
Waeber, 1995, [3H]sumatriptan labels both 5-HT1D and 5-HT1F receptor binding sites in the guinea pig brain: an autoradiographic study, Naunyn-Schmiedeberg’s Arch. Pharmacol., 352, 263, 10.1007/BF00168556
Waeber, 1988, Molecular pharmacology of 5-HT1D recognition sites: radioligand binding studies in human, pig and calf brain membranes, Naunyn-Schmiedeberg’s Arch. Pharmacol., 337, 595, 10.1007/BF00175783
Waeber, 1990, The serotonin 5-HT1D receptor: a progress review, Neurochem. Res., 15, 567, 10.1007/BF00973745
Waeber, 1990, 5-HT1D receptors in the guinea pig brain: pre- and postsynaptic localizations in the striatonigral pathway, Brain Res., 528, 197, 10.1016/0006-8993(90)91658-4
Waeber, 1993, [3H]GR113 808 labels 5-HT(4) receptors in the human and guinea pig brain, NeuroReport, 4, 1239, 10.1097/00001756-199309000-00007
Wainscott, 1993, Pharmacological characteristics of the newly cloned rat 5-hydroxytryptamine2F receptor, Mol. Pharmacol., 43, 419
Ward, 1995, Co-localisation of serotonin 5-HT6 and 5-HT2C receptors in neuropeptide containing neurons of the rat striatum, Soc. Neurosci. Abstr., 21, 728.7
Ward, 1995, Localization of serotonin subtype 6 receptor messenger RNA in the rat brain by in situ hybridisation histochemistry, Neuroscience, 64, 1105, 10.1016/0306-4522(94)00439-C
Weinshank, 1992, Human serotonin1D receptor is encoded by a subfamily of two distinct genes: 5-HT1Dα and 5-HT1Dβ, Proc. Natl. Acad. Sci. USA, 89, 3630, 10.1073/pnas.89.8.3630
Weiss, 1998, Comparative biochemical and pharmacological characterization of the mouse 5-HT5A 5-hydroxytryptamine receptor and the human β2-adrenergic receptor produced in the methylotropic yeast Pichia pastoris, Biochem. J., 330, 1137, 10.1042/bj3301137
Weissmann-Nanopoulus, 1985, Evidence for the localisation of 5-HT1A binding sites on serotonin containing neurones in the raphe dorsalis and raphe centralis nuclei of the rat brain, Neurochem. Int., 7, 1061, 10.1016/0197-0186(85)90156-1
Werner, 1994, Organization of the mouse 5-HT3 receptor gene and functional expression of two splice variants, Mol. Brain Res., 26, 233, 10.1016/0169-328X(94)90095-7
Wilkinson, 1994, 5-HT1A receptor activation increases hippocampal acetylcholine efflux and motor activity in the guinea pig: agonist efficacy influences functional activity in vivo, J. Pharmacol. Exp. Ther., 270, 656
Williams, 1992, 5-HT3 receptors are not involved in the modulation of the K+-evoked release of 3H-5-HT from spinal cord synaptosomes of rat, Neuropharmacology, 31, 725, 10.1016/0028-3908(92)90033-L
Wisden, 1993, Cloning and characterization of the rat 5-HT5B receptor: evidence that the 5-HT5B receptor couples to a G-protein in mammalian cell membranes, FEBS lett., 333, 25, 10.1016/0014-5793(93)80368-5
Witz, 1990, Cloning and characterization of a Drosophila serotonin receptor that activates adenylate cyclase, Proc. Natl. Acad. Sci., 87, 8940, 10.1073/pnas.87.22.8940
Wright, 1995, Comparative localization of serotonin1A, 1C, and 2 receptor subtype mRNAs in rat brain, J. Comp. Neurol., 351, 357, 10.1002/cne.903510304
Xie, E., Zhao, L., Levine, A.J., et al., 1996. Human serotonin 5-HT2C receptor gene: complete cDNA, genomic structure, and alternatively spliced variant. EMBL accession number U49516.
Yakel, 1993, Single amino acid substitution affects desensitization of the 5-hydroxytryptamine-3 receptor expressed in Xenopus oocytes, Proc. Natl. Acad. Sci., 90, 5030, 10.1073/pnas.90.11.5030
Yamaguchi, 1997, Evidence for 5-HT4 receptor involvement in the enhancement of acetylcholine release by p-chloroamphetamine, Brain Res., 772, 95, 10.1016/S0006-8993(97)00856-1
Yamaguchi, 1997, Facilitation of acetylcholine release in rat frontal cortex by indeloxazine hydrochloride: involvement of endogenous serotonin and 5-HT4 receptors, Naunyn-Schmiedeberg’s Arch. Pharmacol., 356, 712, 10.1007/PL00005110
Yan, 1997, Effects of neonatal serotonin depletion on the development of rat dentate granule cells, Dev. Brain Res., 98, 177, 10.1016/S0165-3806(96)00176-9
Yang, 1992, 5-HT3 receptor channels in dissociated rat superior cervical ganglion neurons, J. Physiol., 448, 237, 10.1113/jphysiol.1992.sp019039
Yau, 1997, Impact of adrenalectomy on 5-HT6 and 5-HT7 receptor gene expression in the rat hippocampus, Mol. Brain Res., 45, 182, 10.1016/S0169-328X(97)00026-0
Ying, 1997, 5-HT7 receptors mediate serotonergic effects on light-sensitive suprachiasmatic nucleus neurons, Brain Res., 755, 246, 10.1016/S0006-8993(97)00102-9
Yocca, 1992, Lack of apparent receptor reserve at postsynaptic 5-hydroxytryptamine1A receptors negtively coupled to adenylyl cyclase activity in rat hippocampal membranes, Mol. Pharmacol., 41, 1066
Yoshioka, 1998, Central distribution and function of 5-HT6 receptor subtype in the rat brain, Life Sci., 62, 1473, 10.1016/S0024-3205(98)00092-7
Yu, 1991, The mouse 5-HT1C receptor contains eight hydrophobic domains and is X-linked, Mol. Brain Res., 11, 143, 10.1016/0169-328X(91)90116-F
Yu, 1997, NMDA channel regulation by channel-associated protein tyrosine kinase Src, Science, 275, 674, 10.1126/science.275.5300.674
Zeise, 1994, The 5-HT3 receptor agonist 2-methyl-5-HT reduces postsynaptic potentials in rat CA1 pyramidal neurons of the hippocampus in vitro, Brain Res., 651, 337, 10.1016/0006-8993(94)90715-3
Zetterström, 1996, Local application of 5-HT4 antagonists inhibits potassium-stimulated GABA efflux from rat substantia nigra in vivo, Br. J. Pharmacol., 119, 347P
Zgombick, 1992, Human gene S31 encodes the pharmacologically defined serotonin 5-hydroxytryptamine1E receptor, Mol. Pharmacol., 42, 180